<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29674955</article-id>
<article-id pub-id-type="pmc">5895746</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00111</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pozzi</surname>
<given-names>Davide</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/173169/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Menna</surname>
<given-names>Elisabetta</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/103232/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Canzi</surname>
<given-names>Alice</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/543814/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Desiato</surname>
<given-names>Genni</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/543752/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mantovani</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/516491/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matteoli</surname>
<given-names>Michela</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/1851/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Biomedical Sciences, Humanitas University</institution>, <addr-line>Rozzano</addr-line>, <country>Italy</country></aff>
<aff id="aff2"><sup>2</sup><institution>Humanitas Clinical and Research Center</institution>, <addr-line>Rozzano</addr-line>, <country>Italy</country></aff>
<aff id="aff3"><sup>3</sup><institution>Istituto di Neuroscienze, Consiglio Nazionale delle Ricerche</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff4"><sup>4</sup><institution>School of Medicine and Surgery, University of Milan-Bicocca</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Andras Bilkei-Gorzo, Universität Bonn, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Luigia Trabace, University of Foggia, Italy; Rommy Von Bernhardi, Pontificia Universidad Católica de Chile, Chile</p>
</fn>
<corresp id="c001">*Correspondence: Davide Pozzi, <email>Davide.pozzi@humanitasresearch.it</email> Elisabetta Menna, <email>e.menna@in.cnr.it</email> Michela Matteoli, <email>m.matteoli@in.cnr.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>111</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Pozzi, Menna, Canzi, Desiato, Mantovani and Matteoli.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Pozzi, Menna, Canzi, Desiato, Mantovani and Matteoli</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>In the last 15 years, groundbreaking genetic progress has underlined a convergence onto coherent synaptic pathways for most psychiatric and neurodevelopmental disorders, which are now collectively called “synaptopathies.” However, the modest size of inheritance detected so far indicates a multifactorial etiology for these disorders, underlining the key contribution of environmental effects to them. Inflammation is known to influence the risk and/or severity of a variety of synaptopathies. In particular, pro-inflammatory cytokines, produced and released in the brain by activated astrocytes and microglia, may play a pivotal role in these pathologies. Although the link between immune system activation and defects in cognitive processes is nowadays clearly established, the knowledge of the molecular mechanisms by which inflammatory mediators specifically hit synaptic components implicated in synaptopathies is still in its infancy. This review summarizes recent evidence showing that the pro-inflammatory cytokine interleukin-1β (IL-1β) specifically targets synaptopathy molecular substrate, leading to memory defects and pathological processes. In particular, we describe three specific pathways through which IL-1β affects (1) synaptic maintenance/dendritic complexity, (2) spine morphology, and (3) the excitatory/inhibitory balance. We coin the term immune synaptopathies to identify this class of diseases.</p>
</abstract>
<kwd-group>
<kwd>synaptopathies</kwd>
<kwd>inflammation</kwd>
<kwd>cytokines</kwd>
<kwd>IL-1β</kwd>
<kwd>IL1RAPL1</kwd>
<kwd>neurodevelopmental diseases</kwd>
<kwd>KCC2</kwd>
<kwd>MeCP2</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="157"></ref-count>
<page-count count="11"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>A large amount of evidence about the genetic architecture of psychiatric and neurodevelopmental diseases has progressively accumulated in the last 15 years or so. The identified pathways typically involve proteins chiefly affecting synapse formation and maintenance, a discovery which has led to the concept of “synaptopathies” (<xref ref-type="bibr" rid="B52">Grant, 2012</xref>). The initial excitement raised by these findings has been, however, tempered by the awareness that understanding a given synaptopathy at the level of its genetic, molecular, and synaptic dysfunction is typically insufficient to explain the disease onset, which depends indeed on additional genetic, epigenetic, and environmental factors (<xref ref-type="bibr" rid="B13">Beutner et al., 2007</xref>; <xref ref-type="bibr" rid="B109">Oh-Nishi et al., 2010</xref>; <xref ref-type="bibr" rid="B29">De Chiara et al., 2012</xref>; <xref ref-type="bibr" rid="B100">Millan, 2013</xref>; <xref ref-type="bibr" rid="B48">Giovanoli et al., 2016</xref>).</p>
<p>Inflammation is increasingly recognized as a key factor influencing physiology and pathology in the immature and mature brain, which can be exposed to inflammation in connection with viral or bacterial prenatal or postnatal infections or as a result of sterile CNS insults (<xref ref-type="bibr" rid="B56">Hagberg et al., 2015</xref>). Extensive research is providing evidence that inflammation has long-term consequences and could speculatively affect the risk and/or severity of a variety of brain diseases, including autism spectrum disorders (ASDs), schizophrenia, and intellectual disabilities (IDs), which represent recognized synaptopathies (<xref ref-type="bibr" rid="B39">Fan et al., 2007</xref>; <xref ref-type="bibr" rid="B28">Dantzer et al., 2008</xref>; <xref ref-type="bibr" rid="B107">Najjar et al., 2013</xref>). Accordingly, prenatal and early postnatal infections have been associated with increased risk for a number of neurodevelopmental disorders (<xref ref-type="bibr" rid="B17">Brown and Derkits, 2010</xref>; <xref ref-type="bibr" rid="B55">Hagberg et al., 2012</xref>; <xref ref-type="bibr" rid="B93">Lipina et al., 2013</xref>; <xref ref-type="bibr" rid="B149">Wischhof et al., 2015</xref>; <xref ref-type="bibr" rid="B51">Graham et al., 2018</xref>).</p>
<p>Pro-inflammatory cytokines, including interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNFα), appear to be at the forefront in the communication between the immune and the nervous system, playing dual roles in mediating physiological and neuroprotective roles in normal brain function (<xref ref-type="bibr" rid="B86">Kushima et al., 1992</xref>; <xref ref-type="bibr" rid="B151">Yamada and Hatanaka, 1994</xref>; <xref ref-type="bibr" rid="B1">Akaneya et al., 1995</xref>; <xref ref-type="bibr" rid="B65">Hirota et al., 1996</xref>; <xref ref-type="bibr" rid="B146">Wagner, 1996</xref>; <xref ref-type="bibr" rid="B41">Gadient and Otten, 1997</xref>; <xref ref-type="bibr" rid="B113">Parish et al., 2002</xref>; <xref ref-type="bibr" rid="B108">Nakanishi et al., 2007</xref>; <xref ref-type="bibr" rid="B63">Heese, 2017</xref>) or being detrimental and associated with brain diseases, especially when present at elevated concentrations (<xref ref-type="bibr" rid="B152">Yan et al., 1992</xref>; <xref ref-type="bibr" rid="B77">Katila et al., 1994</xref>; <xref ref-type="bibr" rid="B41">Gadient and Otten, 1997</xref>; <xref ref-type="bibr" rid="B124">Samuelsson et al., 2006</xref>; <xref ref-type="bibr" rid="B44">Garay and McAllister, 2010</xref>; <xref ref-type="bibr" rid="B4">Ashwood et al., 2011</xref>; <xref ref-type="bibr" rid="B130">Suzuki et al., 2011</xref>; <xref ref-type="bibr" rid="B148">Wei et al., 2011</xref>; <xref ref-type="bibr" rid="B38">Erta et al., 2012</xref>; <xref ref-type="bibr" rid="B22">Chase et al., 2016</xref>; <xref ref-type="bibr" rid="B111">O’Keeffe, 2017</xref>). In particular, experiments performed in rodents have unequivocally demonstrated that inflammation correlates with defective learning and memory paradigms. As an example, influenza infection associated to elevated pro-inflammatory cytokines was found to alter neuronal morphology leading to cognitive impairment in adult mice (<xref ref-type="bibr" rid="B75">Jurgens et al., 2012</xref>; <xref ref-type="bibr" rid="B66">Hosseini et al., 2018</xref>). Although the link between immune system activation and defects in cognition is solidly established, the molecular underpinnings of this correlation are not completely clear. In particular, the knowledge of whether inflammatory mediators specifically hit synaptic components, previously identified by genetic studies as implicated in synaptopathies, is poor and somehow fragmentary.</p>
</sec>
<sec>
<title>Excessive IL-1β Impairs Neuronal Plasticity and Memory</title>
<p>Interleukin-1β is a potent inflammatory cytokine and a fundamental component of the innate immune response (<xref ref-type="bibr" rid="B34">Dinarello, 1996</xref>). Besides affecting several organs during inflammatory processes, IL-1β also exerts a number of diverse actions in the central nervous system (CNS) as important mediator of neuronal injury. Twenty years of research have indeed indicated that IL-1β is involved in several brain diseases, including multiple sclerosis (<xref ref-type="bibr" rid="B92">Lin and Edelson, 2017</xref>), Alzheimer disease (<xref ref-type="bibr" rid="B53">Griffin et al., 2006</xref>), epilepsy (<xref ref-type="bibr" rid="B71">Iori et al., 2016</xref>), stroke (<xref ref-type="bibr" rid="B106">Murray et al., 2015</xref>), and even neurodevelopmental disorders such as schizophrenia and autism (<xref ref-type="bibr" rid="B128">Soderlund et al., 2009</xref>; <xref ref-type="bibr" rid="B49">Girard et al., 2010</xref>; <xref ref-type="bibr" rid="B83">Krakowiak et al., 2017</xref>).</p>
<p>Despite the heterogeneity of the diseases in which IL-1β is involved, a growing body of evidence points toward a shared physiological process hit by the cytokine: cognition. This concept originally emerged as the result of a series of pioneer experiments showing that the intraperitoneal or intrahippocampal injection of the cytokine results in learning and memory defects (<xref ref-type="bibr" rid="B110">Oitzl et al., 1993</xref>; <xref ref-type="bibr" rid="B46">Gibertini et al., 1995</xref>; <xref ref-type="bibr" rid="B8">Barrientos et al., 2002</xref>). The detrimental effects of IL-1β on cognition were later confirmed using transgenic mice expressing the cytokine in an inducible manner (<xref ref-type="bibr" rid="B64">Hein et al., 2010</xref>) or upon endogenous IL-1β elevations evoked by infections (<xref ref-type="bibr" rid="B46">Gibertini et al., 1995</xref>; <xref ref-type="bibr" rid="B7">Barrientos et al., 2006</xref>; <xref ref-type="bibr" rid="B23">Chen et al., 2008</xref>), with the memory deficits being prevented, in the latter case, by intraventricular infusion of the naturally occurring interleukin-1 receptor antagonist (IL-1ra; <xref ref-type="bibr" rid="B50">Goshen et al., 2007</xref>; <xref ref-type="bibr" rid="B6">Barrientos et al., 2009</xref>; <xref ref-type="bibr" rid="B40">Frank et al., 2010</xref>).</p>
<p>In line with the induction of cognitive defects, excessive IL-1β affects long-term potentiation (LTP), the synaptic process which underlies learning and memory. Indeed, elevated levels of IL-1β inhibit LTP in several regions of the hippocampus, including CA1 (<xref ref-type="bibr" rid="B10">Bellinger et al., 1993</xref>; <xref ref-type="bibr" rid="B120">Ross et al., 2003</xref>), CA3 (<xref ref-type="bibr" rid="B78">Katsuki et al., 1990</xref>), and dentate gyrus (<xref ref-type="bibr" rid="B105">Murray and Lynch, 1998</xref>; <xref ref-type="bibr" rid="B79">Kelly et al., 2003</xref>). Of note, the synaptic potentiation processes are not only affected in different pathological scenarios, but also during aging, when the overproduction of IL-1β and/or a synapse-specific IL-1 receptor subunit reconfiguration may produce specific deficits in consolidation of hippocampus-dependent memory (<xref ref-type="bibr" rid="B114">Patterson, 2015</xref>; <xref ref-type="bibr" rid="B116">Prieto et al., 2015</xref>) and also during stress-related conditions, a particular pathophysiological state which might deeply affect immature brain (<xref ref-type="bibr" rid="B9">Barron et al., 2017</xref>; <xref ref-type="bibr" rid="B33">Depino, 2017</xref>; <xref ref-type="bibr" rid="B126">Schiavone and Trabace, 2017</xref>).</p>
</sec>
<sec>
<title>IL-1β Affects Synapse Structure and Function</title>
<p>An extensive series of evidence accumulated over the last 10 years has pointed to the concept that IL-1β directly affects synapse structure and function. Indeed, early experiments performed in primary cultured neurons exposed to recombinant IL-1β revealed a significant decline in the levels of the synaptic vesicle protein synaptophysin (<xref ref-type="bibr" rid="B91">Li et al., 2003</xref>) and in the number of synaptic sites (<xref ref-type="bibr" rid="B101">Mishra et al., 2012</xref>). The occurrence of deleterious cytokine effects on the synapse structure has been reported in different non-neurological disorders associated to increases of IL-1β levels, like sepsis and obesity, where mice show memory impairment and reduced number of hippocampal and cortical excitatory synapses, through a mechanism fully prevented by the addition of IL-1ra (<xref ref-type="bibr" rid="B37">Erion et al., 2014</xref>; <xref ref-type="bibr" rid="B104">Moraes et al., 2015</xref>).</p>
<p>Different mechanisms have been called into question to shed light on the association between excessive IL-1β and synaptic alterations, including the modulation of the mitogen-activated protein kinase (MAPK) pathway and the modification of trophic factor production, such as brain-derived neurotrophic factor (BDNF). These processes have been thoroughly analyzed in a previous review (<xref ref-type="bibr" rid="B114">Patterson, 2015</xref>). Conversely, it is still unclear whether IL-1β may directly act on neuronal proteins involved in modulating the structure and function of dendritic spines and known to be the molecular targets of synaptopathies. In this review, we will illustrate some recently reported data showing that IL-1β may directly interfere with synaptic processes known to be at the root of neurodevelopmental diseases. The research was performed through PubMed. Inclusion criteria were based on the indicated keywords. Only peer-reviewed original articles and reviews were considered.</p>
</sec>
<sec>
<title>IL1RAPL1 and Synapse Stabilization</title>
<p>Interleukin-1-receptor accessory protein like 1 (IL1RAPL1) is a member of the interleukin-1 receptor family. It is selectively expressed in the brain (<xref ref-type="bibr" rid="B19">Carrie et al., 1999</xref>; <xref ref-type="bibr" rid="B14">Born et al., 2000</xref>), where it is mainly localized at excitatory synapses. Mutations in the gene encoding for IL1RAPL1 have been found in patients with cognitive impairments ranging from non-syndromic ID to ASD (<xref ref-type="bibr" rid="B119">Ramos-Brossier et al., 2015</xref>). Indeed, IL1RAPL1 KO mice display a reduction of spine density in the cortex (<xref ref-type="bibr" rid="B153">Yasumura et al., 2014</xref>) and in the CA1 region of the hippocampus (<xref ref-type="bibr" rid="B115">Pavlowsky et al., 2010</xref>; <xref ref-type="bibr" rid="B153">Yasumura et al., 2014</xref>) and are characterized by altered excitation/inhibition (E/I) balance in the cerebellum and amygdala (<xref ref-type="bibr" rid="B42">Gambino et al., 2009</xref>; <xref ref-type="bibr" rid="B67">Houbaert et al., 2013</xref>). These molecular and functional alterations are associated with memory deficits (<xref ref-type="bibr" rid="B67">Houbaert et al., 2013</xref>; <xref ref-type="bibr" rid="B153">Yasumura et al., 2014</xref>). In neurons, IL1RAPL1 plays a role in presynaptic differentiation, in spine formation and stabilization (<xref ref-type="bibr" rid="B115">Pavlowsky et al., 2010</xref>; <xref ref-type="bibr" rid="B141">Valnegri et al., 2011</xref>; <xref ref-type="bibr" rid="B156">Yoshida et al., 2011</xref>; <xref ref-type="bibr" rid="B119">Ramos-Brossier et al., 2015</xref>), and in dendritic morphology (<xref ref-type="bibr" rid="B103">Montani et al., 2017</xref>). Also IL1RAPL1 C-terminus interacts with the neuronal calcium sensor-1 which regulates voltage-gated calcium channel activity (<xref ref-type="bibr" rid="B42">Gambino et al., 2009</xref>). Thus, IL1RAPL1 may promote excitatory synapse formation through two main mechanisms: (i) a trans-synaptic signaling pathway involving the receptor tyrosine phosphatase δ (PTPδ) and RhoGAP2 (<xref ref-type="bibr" rid="B141">Valnegri et al., 2011</xref>) and (ii) the control of synaptic localization of PSD-95 through c-Jun N-terminal kinase (JNK) activity and PSD-95 phosphorylation (<xref ref-type="bibr" rid="B115">Pavlowsky et al., 2010</xref>).</p>
<p>IL1RAPL1 mediates some of the effects of IL-1β in neurons (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, pathway 1), controlling, in particular, the cytokine effects on dendritic morphology, possibly through the involvement of JNK pathway (<xref ref-type="bibr" rid="B115">Pavlowsky et al., 2010</xref>; <xref ref-type="bibr" rid="B103">Montani et al., 2017</xref>). IL1RAPL1 represents therefore the first identified synaptic target of IL-1β. The primary role of the protein in neuronal and synaptic development, together with the observation that IL1RAPL1 is a synaptopathy-related gene, identifies this protein as one of the possible key targets of the immune-to-neuron communication mediated by IL-1β. The future identification of the precise mechanisms by which IL1RAPL1 modulates the activity of IL-1β could offer the opportunity to specifically interfere with the vicious, harmful cycle leading to synapse dysfunction.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Cartoon depicting three possible pathways through which IL-1β might affect synaptic function and structure by acting on IL-R1 which is localized at synaptic site (<xref ref-type="bibr" rid="B45">Gardoni et al., 2011</xref>). <italic>Pathway 1</italic>: IL1RAPL1 mediates some of the effects of IL-1β in neurons, altering dendritic morphology. <italic>Pathway 2</italic>: IL-1β affects spine morphogenesis enhancing the expression of the transcription factor Mecp2, which in turn alters the expression of synaptic proteins via chromatin-remodeling mechanisms. <italic>Pathway3</italic>: IL-1β modulates the excitatory to inhibitory switch of GABA by reducing the expression of the chloride transporter KCC2, leading to E/I unbalance and higher susceptibility to seizures. Pathways 2 and 3 could be linked based on the REST/MeCP2 ability to bind KCC2 gene promoter and act as a repressor of the transporter transcription (see text for details).</p>
</caption>
<graphic xlink:href="fnmol-11-00111-g001"></graphic>
</fig>
</sec>
<sec>
<title>MeCp2 and Spine “Dysgenesis”</title>
<p>Recent studies have exploited a genetic mouse model of IL-1β deregulation, the IL-1R8 KO mice, as a reliable and reproducible system for examining the effects of inflammation on synapse structure and function, also elucidating the molecular processes involved (<xref ref-type="bibr" rid="B27">Costello et al., 2011</xref>; <xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>). IL-1R8, also known as single Ig IL-1 related receptor (SIGIRR), reduces the activation of the Toll-like receptors (TLRs; protein sensors for microorganisms and tissue damage) and IL1R signaling pathways by intracellularly interfering with the association of adaptor molecules to the receptor complex including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and JNK, thus leading to upregulation of IL-1 signaling. Mice lacking IL-1R8, previously shown to exhibit LTP deficits (<xref ref-type="bibr" rid="B27">Costello et al., 2011</xref>), have been used to investigate the mechanisms through which exaggerated inflammatory conditions impact synapse functions. IL-1R8KO neurons were found to display an increased number of immature, thin spines, and a decreased number of mature, mushroom spines, accompanied by reduction of PSD95 expression and impairment of synaptic plasticity (<xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>). The phenotype was rescued by IL-1ra, thus proving the direct involvement of IL-1β signaling (<xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>). The structural and functional alterations were found to be causally linked to upregulation of the mammalian target of rapamycin (mTOR) pathway and increased levels of the epigenetic regulator methyl CpG binding protein 2 (MeCP2), which were again normalized by IL-1Ra treatment (<xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>). The demonstration that enhanced IL-1β signaling increases the expression of MeCP2, thus negatively impacting synapse function, points to this factor as a potentially fundamental node linking inflammation and synaptic damage (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, pathway 2). Of note, alterations in the expression of MeCP2 are known to be responsible of neurodevelopmental diseases in humans: sporadic, loss-of-function mutations in the gene coding for MeCP2 result in Rett syndrome (<xref ref-type="bibr" rid="B2">Amir et al., 1999</xref>), while a double dosage of MeCP2 causes a severe developmental delay and ID, with even mild over-expression having a robust effect (<xref ref-type="bibr" rid="B32">Delobel et al., 1998</xref>; <xref ref-type="bibr" rid="B142">Van Esch et al., 2005</xref>). Interestingly, IL-1Ra reduces MeCP2 levels in wild-type neurons which, concomitantly, lose the ability to undergo LTP (<xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>). It appears therefore that the effects of IL-1β on neuronal plasticity follow a U-shaped dose–response curve, with levels in either excess or below the physiological range being deleterious to neuronal functions, which is exactly the case of MeCP2, whose levels need to be tightly regulated to guarantee a proper neuronal function (<xref ref-type="bibr" rid="B24">Cheng and Qiu, 2014</xref>; <xref ref-type="bibr" rid="B94">Lombardi et al., 2015</xref>). It will be important to assess whether the IL-1β-mediated modulation of MeCP2 also occurs in humans and to define the molecular mechanisms by which the cytokine modulates MeCP2 levels.</p>
</sec>
<sec>
<title>KCC2 and the Excitatory/Inhibitory Balance</title>
<p>Several lines of evidence have highlighted the capacity of IL-1β to promote an imbalance between excitation and inhibition, thus affecting neuronal network excitability. The first indications were obtained in the peripheral nervous system, where elevated levels of pro-inflammatory cytokines, including IL-1β, were found to alter neuronal excitability facilitating pain and hyperalgesia (<xref ref-type="bibr" rid="B145">Viviani et al., 2007</xref>; <xref ref-type="bibr" rid="B125">Schafers and Sorkin, 2008</xref>). Further studies conducted on the CNS have subsequently demonstrated that high levels of IL-1β, as occurring in neurological disorders such as multiple sclerosis and epilepsy, lead to an E/I imbalance, which might be responsible for – or contribute to – cognitive impairment (<xref ref-type="bibr" rid="B143">Vezzani et al., 2008</xref>; <xref ref-type="bibr" rid="B121">Rossi et al., 2012</xref>; <xref ref-type="bibr" rid="B71">Iori et al., 2016</xref>). Among the possible mechanisms, neuronal network hyperactivity may be the result of an altered excitatory-to-inhibitory switch of GABA signaling, leading to a reduced inhibitory action of GABA (<xref ref-type="bibr" rid="B43">Ganguly et al., 2001</xref>; <xref ref-type="bibr" rid="B137">Tyzio et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Ben-Ari et al., 2012b</xref>), a process tightly controlled by the developmentally regulated expression of the two chloride co-transporters, potassium-chloride cotransporter 2 (KCC2) and neuronal Na–K–Cl cotransporter 1 (nKCC1) (<xref ref-type="bibr" rid="B11">Ben-Ari et al., 2012a</xref>; <xref ref-type="bibr" rid="B147">Watanabe and Fukuda, 2015</xref>; <xref ref-type="bibr" rid="B118">Raimondo et al., 2017</xref>). This evidence raised the question of whether an inflammatory event occurring during brain development may specifically affect this process. Such possibility has been called into question in a recent study, where an immune challenge – consisting in the injection of the viral mimicking molecule polyinosinic–polycytidylic acid (poly I:C) – was delivered to pregnant mice at early stages of embryo development (E9, corresponding to the mid/end of first trimester pregnancy in humans), a model of prenatal infection called maternal immune activation (MIA). The prenatal immune activation resulted in a delay of GABA switch in the offspring, resulting from a higher cortical and hippocampal expression of the transporter nKCC1 and a lower expression of KCC2 compared to controls. The alterations in nKCC1/KCC2 ratio resulted in GABA being excitatory and offspring more susceptible to seizures in the adult stage. The involvement of IL-1β in the process was indicated by the evidence that (i) IL1RKO embryos are protected from this detrimental effect and (ii) IL-1β delays the transition of GABA signaling in cultured neurons (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>, pathway 3; <xref ref-type="bibr" rid="B26">Corradini et al., 2017</xref>). Among the transcriptional regulators of KCC2 expression, the neuronal repressor gene RE1-silencing transcription factor (REST) was found to modulate <italic>kcc2</italic> gene expression (<xref ref-type="bibr" rid="B154">Yeo et al., 2009</xref>) and, in line with this evidence, its binding to KCC2 promoter was enhanced in the brain of offspring exposed to MIA (<xref ref-type="bibr" rid="B26">Corradini et al., 2017</xref>). However, given that MeCP2 also acts as a transcriptional repressor by binding to the KCC2 gene promoter (<xref ref-type="bibr" rid="B131">Tang et al., 2016</xref>), it will be interesting to define the interplay between these two factors and whether the increase of MeCP2 levels induced by IL-1β (<xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>) might contribute to KCC2 reduction.</p>
<p>The demonstration that a transient increase of IL-1β during neuronal development may induce long-lasting neuronal network hyperactivity by delaying GABA switch opens unexpected scenarios: impairment of the GABA developmental switch is indeed an important feature of several neurodevelopmental disorders, such as Down syndrome, Rett syndrome, and ASD (<xref ref-type="bibr" rid="B89">Lemonnier et al., 2012</xref>; <xref ref-type="bibr" rid="B62">He et al., 2014</xref>; <xref ref-type="bibr" rid="B138">Tyzio et al., 2014</xref>; <xref ref-type="bibr" rid="B30">Deidda et al., 2015</xref>; <xref ref-type="bibr" rid="B70">Inui et al., 2017</xref>), for which an important risk factor is represented by prenatal inflammatory conditions (<xref ref-type="bibr" rid="B132">Tarnow-Mordi et al., 2005</xref>; <xref ref-type="bibr" rid="B102">Missault et al., 2014</xref>).</p>
<p>An E/I imbalance has also been demonstrated in other neurological diseases characterized by excessive IL-1β levels, such as multiple sclerosis and epilepsy. In these cases, alternative molecular mechanisms were found to be involved. In a mouse model of multiple sclerosis, IL-1β-mediated inflammation was found to enhance glutamatergic transmission during the early phase of the disease (<xref ref-type="bibr" rid="B20">Centonze et al., 2009</xref>; <xref ref-type="bibr" rid="B121">Rossi et al., 2012</xref>, <xref ref-type="bibr" rid="B122">2014</xref>; <xref ref-type="bibr" rid="B97">Mandolesi et al., 2013</xref>), through modulating vanilloid 1 channels in hippocampus (<xref ref-type="bibr" rid="B121">Rossi et al., 2012</xref>), downregulating the glutamate–aspartate transporter/excitatory amino acid transporter 1 (GLAST/EAAT1) in the cerebellum (<xref ref-type="bibr" rid="B97">Mandolesi et al., 2013</xref>, <xref ref-type="bibr" rid="B96">2017</xref>), and by activating the apoptotic cascade through p53 activation (<xref ref-type="bibr" rid="B122">Rossi et al., 2014</xref>). An IL-1β-dependent enhancement of excitatory neurotransmission has also been reported in epilepsy (<xref ref-type="bibr" rid="B72">Iori et al., 2013</xref>) where danger signals such as High Mobility Group Box 1 (HMGB1) and Toll-like receptor 4 (TLR4) were proposed to mediate the IL-1β-dependent increase in neuronal excitability, through an Src kinase-mediated phosphorylation of the NR2B subunit of the <italic>N</italic>-methyl-<sc>D</sc>-aspartate (NMDA) receptor (<xref ref-type="bibr" rid="B144">Viviani et al., 2003</xref>; <xref ref-type="bibr" rid="B98">Maroso et al., 2010</xref>, <xref ref-type="bibr" rid="B99">2011</xref>). Together these data indicate that IL-1β disrupts the correct E/I equilibrium acting on multiple molecular targets.</p>
</sec>
<sec>
<title>Conclusion and Perspectives</title>
<p>It is now clear that inflammation is an important contributor to defects in brain function, by affecting in particular cognitive processes (<xref ref-type="bibr" rid="B117">Rachal Pugh et al., 2001</xref>; <xref ref-type="bibr" rid="B69">Huang and Sheng, 2010</xref>; <xref ref-type="bibr" rid="B155">Yirmiya and Goshen, 2011</xref>) through concentration-dependent harmful effects induced by the pro-inflammatory cytokine IL-1β. Indeed, recent reports have highlighted the ability of IL-1β to selectively affect cell-to-cell communication in the brain, by targeting specific synaptic pathways (<xref ref-type="bibr" rid="B101">Mishra et al., 2012</xref>; <xref ref-type="bibr" rid="B59">Han et al., 2017</xref>) which are known to be altered in different synaptopathies (see <bold>Figures <xref ref-type="fig" rid="F1">1</xref></bold>, <bold><xref ref-type="fig" rid="F2">2</xref></bold>). Among these, IL1RAPL1, MeCP2, and KCC2 are three central molecular players of neurodevelopmental disorders, whose functionality may be affected by IL-1β.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Schematic representation summarizing the functional effects of the three regulatory pathways controlled by IL-1β. <bold>(A)</bold> IL-1β affects dendritic complexity through IL1RAPL1-dependent mechanisms. This pathway activates JNK and PTPδ intracellular proteins (<xref ref-type="bibr" rid="B103">Montani et al., 2017</xref>). <bold>(B)</bold> IL-1β regulates dendritic spine morphology by upregulating the transcription factor MeCP2 in an mTOR-dependent manner (<xref ref-type="bibr" rid="B135">Tomasoni et al., 2017</xref>). <bold>(C)</bold> IL-1β leads to an excitatory/inhibitory unbalance by delaying the developmentally regulated switch of GABA signaling. This pathway involves the interplay between the two transcription factors REST and MeCP2, which in turn regulates the transcriptional level of KCC2 (<xref ref-type="bibr" rid="B26">Corradini et al., 2017</xref>).</p>
</caption>
<graphic xlink:href="fnmol-11-00111-g002"></graphic>
</fig>
<p>These results may have important translational implications. As an example, the recognition that IL-1β modulates MeCP2 levels opens the challenging possibility to target the immune system for treating neurodevelopmental diseases characterized by altered levels of this transcription factor. Observational clinical data already support the possibility to treat cognitive symptoms by immunomodulatory drugs. Indeed, in patients affected by cryopyrin-associated periodic syndrome (CAPS), a group of rare genetic autoinflammatory diseases with levels of IL-1β being fivefold higher than in healthy individuals, symptoms of ID frequently occur. These cognitive defects are reversed following treatment with IL-1Ra (<xref ref-type="bibr" rid="B5">Bachove and Chang, 2014</xref>) or with specific neutralization of IL-1β with canakinumab (<xref ref-type="bibr" rid="B85">Kuemmerle-Deschner et al., 2011</xref>).</p>
<p>Although the modulation of IL-1β signaling in neurology or psychiatry is still in its infancy, the possibility of selectively inhibiting specific steps in the IL-1β cascade may represent a unique opportunity to treat immune synaptopathies (<bold>Box <xref ref-type="boxed-text" rid="BX1">1</xref></bold>), i.e., synaptic dysfunctions resulting from deregulation of the immune system during brain development. A control of maternal inflammatory parameters during pregnancy may turn out to be a promising strategy to decrease the incidence of immune-mediated neurological or psychiatric illness in adulthood, as a consequence of maternal viral infections. Specific studies aimed at testing the efficacy of different IL-1β blockers that offer potential benefits to patients in individual disease states will be required in the next future.</p>
<boxed-text id="BX1" position="float">
<caption>
<title>Box 1. Synaptopathies and inflammation: the concept of immune-synaptopathies.</title>
</caption>
<p>The term synaptopathy (from Greek συν, syn – together, απτειν, haptein – to clasp, and παθοϛ, pathos) refers to a class of neurological disorders characterized by alterations at the synaptic level (<xref ref-type="bibr" rid="B16">Brose et al., 2010</xref>). The concept of synaptopathy is based on several genetical studies which have identified the involvement, in different diseases, of specific genes whose products converge onto coherent biological pathways controlling various aspects of synaptic structure and function (see <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). Besides neurodevelopmental diseases, other brain diseases have been identified as synaptopathies, including neurodegenerative disorders, such as Alzheimer’s (<xref ref-type="bibr" rid="B80">Kerrigan and Randall, 2013</xref>) and Parkinson’s (<xref ref-type="bibr" rid="B95">Longhena et al., 2017</xref>) diseases. Synaptopathies are therefore defined as resulting from pathological events including synaptic loss (in which synaptic connectivity is compromised), alterations of synaptic functioning (in which the physiological activity of synapses is altered), or both (for a review, see <xref ref-type="bibr" rid="B90">Lepeta et al., 2016</xref>). We introduce the novel term immune-synaptopathy to underline the concept that the activation of the immune system, resulting in the formation of soluble immune mediators (i.e., cytokines), which are the main key effectors of the inflammatory response, directly impacts the physiological activity of the synapse producing a disease state (see text for details).</p>
</boxed-text>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>List of selected synaptic and/or synaptic related gene disease.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Protein</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function</th>
<th align="left" colspan="1" rowspan="1" valign="top">Disease (selected)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Complexin-1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cplx1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transmitter release</td>
<td align="left" colspan="1" rowspan="1" valign="top">HD, SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B15">Brose, 2008</xref>; but also <xref ref-type="bibr" rid="B82">Kishi et al., 2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Complexin-2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cplx2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transmitter release</td>
<td align="left" colspan="1" rowspan="1" valign="top">HD, SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B15">Brose, 2008</xref>; but also <xref ref-type="bibr" rid="B82">Kishi et al., 2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Munc 18-1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stxbp1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transmitter release</td>
<td align="left" colspan="1" rowspan="1" valign="top">AD, EPI, PD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B73">Jacobs et al., 2006</xref>; <xref ref-type="bibr" rid="B123">Saitsu et al., 2008</xref>; <xref ref-type="bibr" rid="B21">Chai et al., 2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SNAP-25</td>
<td align="left" colspan="1" rowspan="1" valign="top">SNAP25</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pre and postsynaptic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">ADHD, SCZ, BP, AD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B134">Thompson et al., 1998</xref>; <xref ref-type="bibr" rid="B87">Kustanovich et al., 2003</xref>; <xref ref-type="bibr" rid="B133">Thapar et al., 2007</xref>; <xref ref-type="bibr" rid="B54">Guerini et al., 2014</xref>; <xref ref-type="bibr" rid="B3">Antonucci et al., 2016</xref>; <xref ref-type="bibr" rid="B68">Houenou et al., 2017</xref>; <xref ref-type="bibr" rid="B76">Kang et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexin-1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nrxn1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD, SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B81">Kim et al., 2008</xref>; <xref ref-type="bibr" rid="B129">Sudhof, 2008</xref>; <xref ref-type="bibr" rid="B140">Vaags et al., 2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin-3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nlgn3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B74">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B129">Sudhof, 2008</xref>; <xref ref-type="bibr" rid="B18">Burrows et al., 2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroligin-4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nlgn4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD, ID, TOU</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B74">Jamain et al., 2003</xref>; <xref ref-type="bibr" rid="B88">Lawson-Yuen et al., 2008</xref>; <xref ref-type="bibr" rid="B129">Sudhof, 2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PSD-95</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dlg4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postsynaptic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B136">Toro and Deakin, 2005</xref>; <xref ref-type="bibr" rid="B84">Kristiansen et al., 2006</xref>; <xref ref-type="bibr" rid="B150">Xing et al., 2016</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PSD-93</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dlg2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postsynaptic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B84">Kristiansen et al., 2006</xref>; <xref ref-type="bibr" rid="B36">Egger et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SAP-102</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dlg3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postsynaptic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xlinked ID, SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B112">Oldmeadow et al., 2014</xref>; <xref ref-type="bibr" rid="B139">Tzschach et al., 2015</xref>; <xref ref-type="bibr" rid="B47">Gieldon et al., 2017</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GLUN2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Grin2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Receptor function</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ, ASD, DEP</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B136">Toro and Deakin, 2005</xref>; <xref ref-type="bibr" rid="B84">Kristiansen et al., 2006</xref>; <xref ref-type="bibr" rid="B157">Zhang et al., 2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SHANK-3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Shank3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postsynaptic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B35">Durand et al., 2007</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DISC1</td>
<td align="left" colspan="1" rowspan="1" valign="top">DISC1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B60">Hayashi-Takagi and Sawa, 2010</xref>; <xref ref-type="bibr" rid="B61">Hayashi-Takagi et al., 2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TNIK</td>
<td align="left" colspan="1" rowspan="1" valign="top">TNiK</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postsynaptic function</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B25">Coba et al., 2012</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">C4 (complement component 4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">C4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic pruning</td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B127">Sekar et al., 2016</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MeCP2</td>
<td align="left" colspan="1" rowspan="1" valign="top">MeCP2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulation of gene expression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B2">Amir et al., 1999</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">FMRP</td>
<td align="left" colspan="1" rowspan="1" valign="top">FMR1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptogenesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">FRAXA, ID, ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B57">Hagerman and Hagerman, 2004</xref>; <xref ref-type="bibr" rid="B58">Hagerman et al., 2004</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gephyrin</td>
<td align="left" colspan="1" rowspan="1" valign="top">GPHN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Receptor function</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD, EPI</td>
<td align="left" colspan="1" rowspan="1" valign="top"><xref ref-type="bibr" rid="B36">Egger et al., 2014</xref>; <xref ref-type="bibr" rid="B31">Dejanovic et al., 2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<attrib>
<italic>AD, Alzheimer’s disease; ADHD, attention deficit hyperactivity disorder; ASD, autism spectrum disorder; BP, bipolar disorder; DEP, depression; EPI, epilepsy; FRAXA, fragile X syndrome; HD, Huntington’s disease; ID, intellectual disability; SCZ, schizophrenia; TOU, Tourette syndrome; Rett, Rett syndrome; X-link ID, X-linked intellectual disability.</italic>
</attrib>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Author Contributions</title>
<p>DP, EM, and MM designed the review outline. All the authors contributed to writing and designing the scheme. CM realized the figure.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The work in our laboratory was supported by Ministero della Salute GR-2011–02347377, Cariplo 2015–0594, AIRC, Project “AMANDA” CUP_B42F16000440005 from Regione Lombardia and CNR Research Project on Aging and Fondazione Veronesi to MM; Fondazione Vodafone to EM and MM; Cariplo no. 2017-0622 and Progetto Bandiera Interomics 2015–2017 to EM. Cariplo no. 2017-0886 to DP. We thank Monzino Foundation (Milano, Italy) for its generous gift of the Zeiss LSM800 confocal microscope to the section of Milan of the Institute of Neuroscience.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akaneya</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Hatanaka</surname><given-names>H.</given-names></name></person-group> (<year>1995</year>). <article-title>Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons.</article-title>
<source/><italic>Exp. Neurol.</italic>
<volume>136</volume>
<fpage>44</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.1995.1082</pub-id>
<pub-id pub-id-type="pmid">7589333</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van Den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>23</volume>
<fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonucci</surname><given-names>F.</given-names></name><name><surname>Corradini</surname><given-names>I.</given-names></name><name><surname>Fossati</surname><given-names>G.</given-names></name><name><surname>Tomasoni</surname><given-names>R.</given-names></name><name><surname>Menna</surname><given-names>E.</given-names></name><name><surname>Matteoli</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>SNAP-25, a known presynaptic protein with emerging postsynaptic functions.</article-title>
<source/><italic>Front. Synaptic Neurosci.</italic>
<volume>8</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.3389/fnsyn.2016.00007</pub-id>
<pub-id pub-id-type="pmid">27047369</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashwood</surname><given-names>P.</given-names></name><name><surname>Krakowiak</surname><given-names>P.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><name><surname>Hansen</surname><given-names>R.</given-names></name><name><surname>Pessah</surname><given-names>I.</given-names></name><name><surname>Van De Water</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>25</volume>
<fpage>40</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2010.08.003</pub-id>
<pub-id pub-id-type="pmid">20705131</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachove</surname><given-names>I.</given-names></name><name><surname>Chang</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes.</article-title>
<source/><italic>Open Access Rheumatol.</italic>
<volume>6</volume>
<fpage>15</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="pmid">27790031</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>R. M.</given-names></name><name><surname>Frank</surname><given-names>M. G.</given-names></name><name><surname>Hein</surname><given-names>A. M.</given-names></name><name><surname>Higgins</surname><given-names>E. A.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Rudy</surname><given-names>J. W.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Time course of hippocampal IL-1 beta and memory consolidation impairments in aging rats following peripheral infection.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>23</volume>
<fpage>46</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2008.07.002</pub-id>
<pub-id pub-id-type="pmid">18664380</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>R. M.</given-names></name><name><surname>Higgins</surname><given-names>E. A.</given-names></name><name><surname>Biedenkapp</surname><given-names>J. C.</given-names></name><name><surname>Sprunger</surname><given-names>D. B.</given-names></name><name><surname>Wright-Hardesty</surname><given-names>K. J.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Peripheral infection and aging interact to impair hippocampal memory consolidation.</article-title>
<source/><italic>Neurobiol. Aging</italic>
<volume>27</volume>
<fpage>723</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.03.010</pub-id>
<pub-id pub-id-type="pmid">15893410</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrientos</surname><given-names>R. M.</given-names></name><name><surname>Higgins</surname><given-names>E. A.</given-names></name><name><surname>Sprunger</surname><given-names>D. B.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Rudy</surname><given-names>J. W.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name></person-group> (<year>2002</year>). <article-title>Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>134</volume>
<fpage>291</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-4328(02)00043-8</pub-id>
<pub-id pub-id-type="pmid">12191816</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barron</surname><given-names>H.</given-names></name><name><surname>Hafizi</surname><given-names>S.</given-names></name><name><surname>Andreazza</surname><given-names>A. C.</given-names></name><name><surname>Mizrahi</surname><given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuroinflammation and oxidative stress in psychosis and psychosis risk.</article-title>
<source/><italic>Int. J. Mol. Sci.</italic>
<volume>18</volume>:<issue>651</issue>. <pub-id pub-id-type="doi">10.3390/ijms18030651</pub-id>
<pub-id pub-id-type="pmid">28304340</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellinger</surname><given-names>F. P.</given-names></name><name><surname>Madamba</surname><given-names>S.</given-names></name><name><surname>Siggins</surname><given-names>G. R.</given-names></name></person-group> (<year>1993</year>). <article-title>Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus.</article-title>
<source/><italic>Brain Res.</italic>
<volume>628</volume>
<fpage>227</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(93)90959-Q</pub-id>
<pub-id pub-id-type="pmid">8313151</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name><name><surname>Khalilov</surname><given-names>I.</given-names></name><name><surname>Kahle</surname><given-names>K. T.</given-names></name><name><surname>Cherubini</surname><given-names>E.</given-names></name></person-group> (<year>2012a</year>). <article-title>The GABA excitatory/inhibitory shift in brain maturation and neurological disorders.</article-title>
<source/><italic>Neuroscientist</italic>
<volume>18</volume>
<fpage>467</fpage>–<lpage>486</lpage>.<pub-id pub-id-type="pmid">22547529</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name><name><surname>Woodin</surname><given-names>M. A.</given-names></name><name><surname>Sernagor</surname><given-names>E.</given-names></name><name><surname>Cancedda</surname><given-names>L.</given-names></name><name><surname>Vinay</surname><given-names>L.</given-names></name><name><surname>Rivera</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012b</year>). <article-title>Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>6</volume>:<issue>35</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2012.00035</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beutner</surname><given-names>D.</given-names></name><name><surname>Foerst</surname><given-names>A.</given-names></name><name><surname>Lang-Roth</surname><given-names>R.</given-names></name><name><surname>Von Wedel</surname><given-names>H.</given-names></name><name><surname>Walger</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Risk factors for auditory neuropathy/auditory synaptopathy.</article-title>
<source/><italic>ORL J. Otorhinolaryngol. Relat. Spec.</italic>
<volume>69</volume>
<fpage>239</fpage>–<lpage>244</lpage>. <pub-id pub-id-type="doi">10.1159/000101545</pub-id>
<pub-id pub-id-type="pmid">17409783</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Born</surname><given-names>T. L.</given-names></name><name><surname>Smith</surname><given-names>D. E.</given-names></name><name><surname>Garka</surname><given-names>K. E.</given-names></name><name><surname>Renshaw</surname><given-names>B. R.</given-names></name><name><surname>Bertles</surname><given-names>J. S.</given-names></name><name><surname>Sims</surname><given-names>J. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation Of a new class of IL-1R-related proteins based on signaling.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>275</volume>
<fpage>29946</fpage>–<lpage>29954</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M004077200</pub-id>
<pub-id pub-id-type="pmid">10882729</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brose</surname><given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Altered complexin expression in psychiatric and neurological disorders: cause or consequence?</article-title>
<source/><italic>Mol. Cells</italic>
<volume>25</volume>
<fpage>7</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">18319609</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brose</surname><given-names>N.</given-names></name><name><surname>O’connor</surname><given-names>V.</given-names></name><name><surname>Skehel</surname><given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Synaptopathy: dysfunction of synaptic function?</article-title>
<source/><italic>Biochem. Soc. Trans</italic>.
<volume>38</volume>
<fpage>443</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1042/BST0380443</pub-id>
<pub-id pub-id-type="pmid">20298199</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A. S.</given-names></name><name><surname>Derkits</surname><given-names>E. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.</article-title>
<source/><italic>Am. J. Psychiatry</italic>
<volume>167</volume>
<fpage>261</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2009.09030361</pub-id>
<pub-id pub-id-type="pmid">20123911</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrows</surname><given-names>E. L.</given-names></name><name><surname>Laskaris</surname><given-names>L.</given-names></name><name><surname>Koyama</surname><given-names>L.</given-names></name><name><surname>Churilov</surname><given-names>L.</given-names></name><name><surname>Bornstein</surname><given-names>J. C.</given-names></name><name><surname>Hill-Yardin</surname><given-names>E. L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A neuroligin-3 mutation implicated in autism causes abnormal aggression and increases repetitive behavior in mice.</article-title>
<source/><italic>Mol. Autism</italic>
<volume>6</volume>:<issue>62</issue>. <pub-id pub-id-type="doi">10.1186/s13229-015-0055-7</pub-id>
<pub-id pub-id-type="pmid">26583067</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrie</surname><given-names>A.</given-names></name><name><surname>Jun</surname><given-names>L.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Vinet</surname><given-names>M. C.</given-names></name><name><surname>Mcdonell</surname><given-names>N.</given-names></name><name><surname>Couvert</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>23</volume>
<fpage>25</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/12623</pub-id>
<pub-id pub-id-type="pmid">10471494</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centonze</surname><given-names>D.</given-names></name><name><surname>Muzio</surname><given-names>L.</given-names></name><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Cavasinni</surname><given-names>F.</given-names></name><name><surname>De Chiara</surname><given-names>V.</given-names></name><name><surname>Bergami</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>3442</fpage>–<lpage>3452</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5804-08.2009</pub-id>
<pub-id pub-id-type="pmid">19295150</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>Y. J.</given-names></name><name><surname>Sierecki</surname><given-names>E.</given-names></name><name><surname>Tomatis</surname><given-names>V. M.</given-names></name><name><surname>Gormal</surname><given-names>R. S.</given-names></name><name><surname>Giles</surname><given-names>N.</given-names></name><name><surname>Morrow</surname><given-names>I. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>214</volume>
<fpage>705</fpage>–<lpage>718</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201512016</pub-id>
<pub-id pub-id-type="pmid">27597756</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chase</surname><given-names>K. A.</given-names></name><name><surname>Cone</surname><given-names>J. J.</given-names></name><name><surname>Rosen</surname><given-names>C.</given-names></name><name><surname>Sharma</surname><given-names>R. P.</given-names></name></person-group> (<year>2016</year>). <article-title>The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia.</article-title>
<source/><italic>BMC Psychiatry</italic>
<volume>16</volume>:<issue>152</issue>. <pub-id pub-id-type="doi">10.1186/s12888-016-0866-x</pub-id>
<pub-id pub-id-type="pmid">27206977</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Buchanan</surname><given-names>J. B.</given-names></name><name><surname>Sparkman</surname><given-names>N. L.</given-names></name><name><surname>Godbout</surname><given-names>J. P.</given-names></name><name><surname>Freund</surname><given-names>G. G.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>22</volume>
<fpage>301</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2007.08.014</pub-id>
<pub-id pub-id-type="pmid">17951027</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>T. L.</given-names></name><name><surname>Qiu</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>). <article-title>MeCP2: multifaceted roles in gene regulation and neural development.</article-title>
<source/><italic>Neurosci. Bull.</italic>
<volume>30</volume>
<fpage>601</fpage>–<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-014-1452-6</pub-id>
<pub-id pub-id-type="pmid">25082535</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coba</surname><given-names>M. P.</given-names></name><name><surname>Komiyama</surname><given-names>N. H.</given-names></name><name><surname>Nithianantharajah</surname><given-names>J.</given-names></name><name><surname>Kopanitsa</surname><given-names>M. V.</given-names></name><name><surname>Indersmitten</surname><given-names>T.</given-names></name><name><surname>Skene</surname><given-names>N. G.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>13987</fpage>–<lpage>13999</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2433-12.2012</pub-id>
<pub-id pub-id-type="pmid">23035106</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corradini</surname><given-names>I.</given-names></name><name><surname>Focchi</surname><given-names>E.</given-names></name><name><surname>Rasile</surname><given-names>M.</given-names></name><name><surname>Morini</surname><given-names>R.</given-names></name><name><surname>Desiato</surname><given-names>G.</given-names></name><name><surname>Tomasoni</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Maternal immune activation delays excitatory-to-inhibitory gamma-aminobutyric acid switch in offspring.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>83</volume>
<fpage>680</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.09.030</pub-id>
<pub-id pub-id-type="pmid">29146047</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costello</surname><given-names>D. A.</given-names></name><name><surname>Watson</surname><given-names>M. B.</given-names></name><name><surname>Cowley</surname><given-names>T. R.</given-names></name><name><surname>Murphy</surname><given-names>N.</given-names></name><name><surname>Murphy Royal</surname><given-names>C.</given-names></name><name><surname>Garlanda</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>3871</fpage>–<lpage>3879</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6676-10.2011</pub-id>
<pub-id pub-id-type="pmid">21389242</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R.</given-names></name><name><surname>O’connor</surname><given-names>J. C.</given-names></name><name><surname>Freund</surname><given-names>G. G.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name></person-group> (<year>2008</year>). <article-title>From inflammation to sickness and depression: when the immune system subjugates the brain.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>9</volume>
<fpage>46</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2297</pub-id>
<pub-id pub-id-type="pmid">18073775</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Chiara</surname><given-names>G.</given-names></name><name><surname>Marcocci</surname><given-names>M. E.</given-names></name><name><surname>Sgarbanti</surname><given-names>R.</given-names></name><name><surname>Civitelli</surname><given-names>L.</given-names></name><name><surname>Ripoli</surname><given-names>C.</given-names></name><name><surname>Piacentini</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Infectious agents and neurodegeneration.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>46</volume>
<fpage>614</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-012-8320-7</pub-id>
<pub-id pub-id-type="pmid">22899188</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deidda</surname><given-names>G.</given-names></name><name><surname>Parrini</surname><given-names>M.</given-names></name><name><surname>Naskar</surname><given-names>S.</given-names></name><name><surname>Bozarth</surname><given-names>I. F.</given-names></name><name><surname>Contestabile</surname><given-names>A.</given-names></name><name><surname>Cancedda</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>21</volume>
<fpage>318</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3827</pub-id>
<pub-id pub-id-type="pmid">25774849</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Djemie</surname><given-names>T.</given-names></name><name><surname>Grunewald</surname><given-names>N.</given-names></name><name><surname>Suls</surname><given-names>A.</given-names></name><name><surname>Kress</surname><given-names>V.</given-names></name><name><surname>Hetsch</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Simultaneous impairment of neuronal and metabolic function of mutated gephyrin in a patient with epileptic encephalopathy.</article-title>
<source/><italic>EMBO Mol. Med.</italic>
<volume>7</volume>
<fpage>1580</fpage>–<lpage>1594</lpage>. <pub-id pub-id-type="doi">10.15252/emmm.201505323</pub-id>
<pub-id pub-id-type="pmid">26613940</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delobel</surname><given-names>B.</given-names></name><name><surname>Delannoy</surname><given-names>V.</given-names></name><name><surname>Pini</surname><given-names>G.</given-names></name><name><surname>Zapella</surname><given-names>M.</given-names></name><name><surname>Tardieu</surname><given-names>M.</given-names></name><name><surname>Vallee</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Identification and molecular characterization of a small 11q23.3 de novo duplication in a patient with Rett syndrome manifestations.</article-title>
<source/><italic>Am. J. Med. Genet.</italic>
<volume>80</volume>
<fpage>273</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19981116)80:3&lt;273::AID-AJMG19&gt;3.0.CO;2-6</pub-id>
<pub-id pub-id-type="pmid">9843053</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depino</surname><given-names>A. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Perinatal inflammation and adult psychopathology: from preclinical models to humans.</article-title>
<source/><italic>Semin. Cell Dev. Biol.</italic>
<volume>77</volume>
<fpage>104</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2017.09.010</pub-id>
<pub-id pub-id-type="pmid">28890420</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>C. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Biologic basis for interleukin-1 in disease.</article-title>
<source/><italic>Blood</italic>
<volume>87</volume>
<fpage>2095</fpage>–<lpage>2147</lpage>.<pub-id pub-id-type="pmid">8630372</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>C. M.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Boeckers</surname><given-names>T. M.</given-names></name><name><surname>Bockmann</surname><given-names>J.</given-names></name><name><surname>Chaste</surname><given-names>P.</given-names></name><name><surname>Fauchereau</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>39</volume>
<fpage>25</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/ng1933</pub-id>
<pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>G.</given-names></name><name><surname>Roetzer</surname><given-names>K. M.</given-names></name><name><surname>Noor</surname><given-names>A.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Mahmood</surname><given-names>H.</given-names></name><name><surname>Schwarzbraun</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families.</article-title>
<source/><italic>Neurogenetics</italic>
<volume>15</volume>
<fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-014-0394-0</pub-id>
<pub-id pub-id-type="pmid">24643514</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erion</surname><given-names>J. R.</given-names></name><name><surname>Wosiski-Kuhn</surname><given-names>M.</given-names></name><name><surname>Dey</surname><given-names>A.</given-names></name><name><surname>Hao</surname><given-names>S.</given-names></name><name><surname>Davis</surname><given-names>C. L.</given-names></name><name><surname>Pollock</surname><given-names>N. K.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>2618</fpage>–<lpage>2631</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4200-13.2014</pub-id>
<pub-id pub-id-type="pmid">24523551</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erta</surname><given-names>M.</given-names></name><name><surname>Quintana</surname><given-names>A.</given-names></name><name><surname>Hidalgo</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Interleukin-6 a major cytokine in the central nervous system.</article-title>
<source/><italic>Int. J. Biol. Sci.</italic>
<volume>8</volume>
<fpage>1254</fpage>–<lpage>1266</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.4679</pub-id>
<pub-id pub-id-type="pmid">23136554</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Goff</surname><given-names>D. C.</given-names></name><name><surname>Henderson</surname><given-names>D. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Inflammation and schizophrenia.</article-title>
<source/><italic>Expert Rev. Neurother.</italic>
<volume>7</volume>
<fpage>789</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1586/14737175.7.7.789</pub-id>
<pub-id pub-id-type="pmid">17610386</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>M. G.</given-names></name><name><surname>Miguel</surname><given-names>Z. D.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to <italic>E. coli</italic> lipopolysaccharide.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>24</volume>
<fpage>19</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.07.008</pub-id>
<pub-id pub-id-type="pmid">19647070</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadient</surname><given-names>R. A.</given-names></name><name><surname>Otten</surname><given-names>U. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Interleukin-6 (IL-6)–a molecule with both beneficial and destructive potentials.</article-title>
<source/><italic>Prog. Neurobiol.</italic>
<volume>52</volume>
<fpage>379</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(97)00021-X</pub-id><pub-id pub-id-type="pmid">9304698</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambino</surname><given-names>F.</given-names></name><name><surname>Kneib</surname><given-names>M.</given-names></name><name><surname>Pavlowsky</surname><given-names>A.</given-names></name><name><surname>Skala</surname><given-names>H.</given-names></name><name><surname>Heitz</surname><given-names>S.</given-names></name><name><surname>Vitale</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>IL1RAPL1 controls inhibitory networks during cerebellar development in mice.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>30</volume>
<fpage>1476</fpage>–<lpage>1486</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2009.06975.x</pub-id>
<pub-id pub-id-type="pmid">19811529</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>K.</given-names></name><name><surname>Schinder</surname><given-names>A. F.</given-names></name><name><surname>Wong</surname><given-names>S. T.</given-names></name><name><surname>Poo</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Gaba itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition.</article-title>
<source/><italic>Cell</italic>
<volume>105</volume>
<fpage>521</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00341-5</pub-id>
<pub-id pub-id-type="pmid">11371348</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garay</surname><given-names>P. A.</given-names></name><name><surname>McAllister</surname><given-names>A. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders.</article-title>
<source/><italic>Front. Synaptic Neurosci.</italic>
<volume>2</volume>:<issue>136</issue>. <pub-id pub-id-type="doi">10.3389/fnsyn.2010.00136</pub-id>
<pub-id pub-id-type="pmid">21423522</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardoni</surname><given-names>F.</given-names></name><name><surname>Boraso</surname><given-names>M.</given-names></name><name><surname>Zianni</surname><given-names>E.</given-names></name><name><surname>Corsini</surname><given-names>E.</given-names></name><name><surname>Galli</surname><given-names>C. L.</given-names></name><name><surname>Cattabeni</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>8</volume>:<issue>14</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-8-14</pub-id>
<pub-id pub-id-type="pmid">21314939</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibertini</surname><given-names>M.</given-names></name><name><surname>Newton</surname><given-names>C.</given-names></name><name><surname>Friedman</surname><given-names>H.</given-names></name><name><surname>Klein</surname><given-names>T. W.</given-names></name></person-group> (<year>1995</year>). <article-title>Spatial learning impairment in mice infected with <italic>Legionella pneumophila</italic> or administered exogenous interleukin-1-beta.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>9</volume>
<fpage>113</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1006/brbi.1995.1012</pub-id>
<pub-id pub-id-type="pmid">7549035</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gieldon</surname><given-names>L.</given-names></name><name><surname>Mackenroth</surname><given-names>L.</given-names></name><name><surname>Betcheva-Krajcir</surname><given-names>E.</given-names></name><name><surname>Rump</surname><given-names>A.</given-names></name><name><surname>Beck-Wodl</surname><given-names>S.</given-names></name><name><surname>Schallner</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Skewed X-inactivation in a family with DLG3-associated X-linked intellectual disability.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>173</volume>
<fpage>2545</fpage>–<lpage>2550</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38348</pub-id>
<pub-id pub-id-type="pmid">28777483</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovanoli</surname><given-names>S.</given-names></name><name><surname>Weber-Stadlbauer</surname><given-names>U.</given-names></name><name><surname>Schedlowski</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>U.</given-names></name><name><surname>Engler</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>55</volume>
<fpage>25</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2015.09.015</pub-id>
<pub-id pub-id-type="pmid">26408796</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>S.</given-names></name><name><surname>Tremblay</surname><given-names>L.</given-names></name><name><surname>Lepage</surname><given-names>M.</given-names></name><name><surname>Sebire</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>184</volume>
<fpage>3997</fpage>–<lpage>4005</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0903349</pub-id>
<pub-id pub-id-type="pmid">20181892</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goshen</surname><given-names>I.</given-names></name><name><surname>Kreisel</surname><given-names>T.</given-names></name><name><surname>Ounallah-Saad</surname><given-names>H.</given-names></name><name><surname>Renbaum</surname><given-names>P.</given-names></name><name><surname>Zalzstein</surname><given-names>Y.</given-names></name><name><surname>Ben-Hur</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>A dual role for interleukin-1 in hippocampal-dependent memory processes.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>32</volume>
<fpage>1106</fpage>–<lpage>1115</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2007.09.004</pub-id>
<pub-id pub-id-type="pmid">17976923</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>A. M.</given-names></name><name><surname>Rasmussen</surname><given-names>J. M.</given-names></name><name><surname>Rudolph</surname><given-names>M. D.</given-names></name><name><surname>Heim</surname><given-names>C. M.</given-names></name><name><surname>Gilmore</surname><given-names>J. H.</given-names></name><name><surname>Styner</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and subsequent behavior at 2 years of age.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>83</volume>
<fpage>109</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.05.027</pub-id>
<pub-id pub-id-type="pmid">28754515</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>S. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Synaptopathies: diseases of the synaptome.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>22</volume>
<fpage>522</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2012.02.002</pub-id>
<pub-id pub-id-type="pmid">22409856</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>W. S.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Mrak</surname><given-names>R. E.</given-names></name><name><surname>Barger</surname><given-names>S. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Interleukin-1 mediates Alzheimer and Lewy body pathologies.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>3</volume>:<issue>5</issue>. <pub-id pub-id-type="pmid">16542445</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerini</surname><given-names>F. R.</given-names></name><name><surname>Agliardi</surname><given-names>C.</given-names></name><name><surname>Sironi</surname><given-names>M.</given-names></name><name><surname>Arosio</surname><given-names>B.</given-names></name><name><surname>Calabrese</surname><given-names>E.</given-names></name><name><surname>Zanzottera</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer’s disease.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>42</volume>
<fpage>1015</fpage>–<lpage>1028</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-140057</pub-id>
<pub-id pub-id-type="pmid">25024311</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Gressens</surname><given-names>P.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>71</volume>
<fpage>444</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22620</pub-id>
<pub-id pub-id-type="pmid">22334391</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagberg</surname><given-names>H.</given-names></name><name><surname>Mallard</surname><given-names>C.</given-names></name><name><surname>Ferriero</surname><given-names>D. M.</given-names></name><name><surname>Vannucci</surname><given-names>S. J.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name><name><surname>Vexler</surname><given-names>Z. S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The role of inflammation in perinatal brain injury.</article-title>
<source/><italic>Nat. Rev. Neurol.</italic>
<volume>11</volume>
<fpage>192</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.13</pub-id>
<pub-id pub-id-type="pmid">25686754</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>P. J.</given-names></name><name><surname>Hagerman</surname><given-names>R. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Fragile X-associated tremor/ataxia syndrome (FXTAS).</article-title>
<source/><italic>Ment. Retard. Dev. Disabil. Res. Rev.</italic>
<volume>10</volume>
<fpage>25</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1002/mrdd.20005</pub-id>
<pub-id pub-id-type="pmid">14994285</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagerman</surname><given-names>R. J.</given-names></name><name><surname>Leavitt</surname><given-names>B. R.</given-names></name><name><surname>Farzin</surname><given-names>F.</given-names></name><name><surname>Jacquemont</surname><given-names>S.</given-names></name><name><surname>Greco</surname><given-names>C. M.</given-names></name><name><surname>Brunberg</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the <italic>FMR1</italic> premutation.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>74</volume>
<fpage>1051</fpage>–<lpage>1056</lpage>. <pub-id pub-id-type="doi">10.1086/420700</pub-id>
<pub-id pub-id-type="pmid">15065016</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q.</given-names></name><name><surname>Lin</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Fu</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Microglia-derived IL-1β contributes to axon development disorders and synaptic deficit through p38-MAPK signal pathway in septic neonatal rats.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>14</volume>:<issue>52</issue>. <pub-id pub-id-type="doi">10.1186/s12974-017-0805-x</pub-id>
<pub-id pub-id-type="pmid">28288671</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi-Takagi</surname><given-names>A.</given-names></name><name><surname>Sawa</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment.</article-title>
<source/><italic>Brain Res. Bull.</italic>
<volume>83</volume>
<fpage>140</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2010.04.007</pub-id>
<pub-id pub-id-type="pmid">20433911</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi-Takagi</surname><given-names>A.</given-names></name><name><surname>Takaki</surname><given-names>M.</given-names></name><name><surname>Graziane</surname><given-names>N.</given-names></name><name><surname>Seshadri</surname><given-names>S.</given-names></name><name><surname>Murdoch</surname><given-names>H.</given-names></name><name><surname>Dunlop</surname><given-names>A. J.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>13</volume>
<fpage>327</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2487</pub-id>
<pub-id pub-id-type="pmid">20139976</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Q.</given-names></name><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Contractor</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>The developmental switch in GABA polarity is delayed in fragile X mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>34</volume>
<fpage>446</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4447-13.2014</pub-id>
<pub-id pub-id-type="pmid">24403144</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heese</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Functional repertoire of interleukin-6 in the central nervous system - a review.</article-title>
<source/><italic>Restor. Neurol. Neurosci.</italic>
<volume>35</volume>
<fpage>693</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.3233/RNN-170772</pub-id>
<pub-id pub-id-type="pmid">29036854</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>A. M.</given-names></name><name><surname>Stasko</surname><given-names>M. R.</given-names></name><name><surname>Matousek</surname><given-names>S. B.</given-names></name><name><surname>Scott-Mckean</surname><given-names>J. J.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name><name><surname>Olschowka</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>24</volume>
<fpage>243</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2009.10.002</pub-id>
<pub-id pub-id-type="pmid">19825412</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>H.</given-names></name><name><surname>Kiyama</surname><given-names>H.</given-names></name><name><surname>Kishimoto</surname><given-names>T.</given-names></name><name><surname>Taga</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma.</article-title>
<source/><italic>J. Exp. Med.</italic>
<volume>183</volume>
<fpage>2627</fpage>–<lpage>2634</lpage>. <pub-id pub-id-type="doi">10.1084/jem.183.6.2627</pub-id>
<pub-id pub-id-type="pmid">8676083</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>S.</given-names></name><name><surname>Wilk</surname><given-names>E.</given-names></name><name><surname>Michaelsen-Preusse</surname><given-names>K.</given-names></name><name><surname>Gerhauser</surname><given-names>I.</given-names></name><name><surname>Baumgartner</surname><given-names>W.</given-names></name><name><surname>Geffers</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>38</volume>
<fpage>3060</fpage>–<lpage>3080</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1740-17.2018</pub-id>
<pub-id pub-id-type="pmid">29487124</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houbaert</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>C. L.</given-names></name><name><surname>Gambino</surname><given-names>F.</given-names></name><name><surname>Lepleux</surname><given-names>M.</given-names></name><name><surname>Deshors</surname><given-names>M.</given-names></name><name><surname>Normand</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Target-specific vulnerability of excitatory synapses leads to deficits in associative memory in a model of intellectual disorder.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>13805</fpage>–<lpage>13819</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1457-13.2013</pub-id>
<pub-id pub-id-type="pmid">23966701</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houenou</surname><given-names>J.</given-names></name><name><surname>Boisgontier</surname><given-names>J.</given-names></name><name><surname>Henrion</surname><given-names>A.</given-names></name><name><surname>D’albis</surname><given-names>M. A.</given-names></name><name><surname>Dumaine</surname><given-names>A.</given-names></name><name><surname>Linke</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A multilevel functional study of a SNAP25 at-risk variant for bipolar disorder and schizophrenia.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>10389</fpage>–<lpage>10397</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1040-17.2017</pub-id>
<pub-id pub-id-type="pmid">28972123</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z. B.</given-names></name><name><surname>Sheng</surname><given-names>G. Q.</given-names></name></person-group> (<year>2010</year>). <article-title>Interleukin-1beta with learning and memory.</article-title>
<source/><italic>Neurosci. Bull.</italic>
<volume>26</volume>
<fpage>455</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-010-6023-5</pub-id>
<pub-id pub-id-type="pmid">21113196</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inui</surname><given-names>T.</given-names></name><name><surname>Kumagaya</surname><given-names>S.</given-names></name><name><surname>Myowa-Yamakoshi</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Neurodevelopmental hypothesis about the etiology of autism spectrum disorders.</article-title>
<source/><italic>Front. Hum. Neurosci.</italic>
<volume>11</volume>:<issue>354</issue>. <pub-id pub-id-type="doi">10.3389/fnhum.2017.00354</pub-id>
<pub-id pub-id-type="pmid">28744208</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iori</surname><given-names>V.</given-names></name><name><surname>Frigerio</surname><given-names>F.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Modulation of neuronal excitability by immune mediators in epilepsy.</article-title>
<source/><italic>Curr. Opin. Pharmacol.</italic>
<volume>26</volume>
<fpage>118</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2015.11.002</pub-id>
<pub-id pub-id-type="pmid">26629681</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iori</surname><given-names>V.</given-names></name><name><surname>Maroso</surname><given-names>M.</given-names></name><name><surname>Rizzi</surname><given-names>M.</given-names></name><name><surname>Iyer</surname><given-names>A. M.</given-names></name><name><surname>Vertemara</surname><given-names>R.</given-names></name><name><surname>Carli</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.</article-title>
<source/><italic>Neurobiol. Dis.</italic>
<volume>58</volume>
<fpage>102</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.03.006</pub-id>
<pub-id pub-id-type="pmid">23523633</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>E. H.</given-names></name><name><surname>Williams</surname><given-names>R. J.</given-names></name><name><surname>Francis</surname><given-names>P. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Cyclin-dependent kinase 5 Munc18a and Munc18-interacting protein 1/X11alpha protein up-regulation in Alzheimer’s disease.</article-title>
<source/><italic>Neuroscience</italic>
<volume>138</volume>
<fpage>511</fpage>–<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.11.017</pub-id>
<pub-id pub-id-type="pmid">16413130</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamain</surname><given-names>S.</given-names></name><name><surname>Quach</surname><given-names>H.</given-names></name><name><surname>Betancur</surname><given-names>C.</given-names></name><name><surname>Rastam</surname><given-names>M.</given-names></name><name><surname>Colineaux</surname><given-names>C.</given-names></name><name><surname>Gillberg</surname><given-names>I. C.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>34</volume>
<fpage>27</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<pub-id pub-id-type="pmid">12669065</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurgens</surname><given-names>H. A.</given-names></name><name><surname>Amancherla</surname><given-names>K.</given-names></name><name><surname>Johnson</surname><given-names>R. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>3958</fpage>–<lpage>3968</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6389-11.2012</pub-id>
<pub-id pub-id-type="pmid">22442063</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Yuan</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Association of the 5-HT<sub>2A</sub> receptor gene promoter polymorphism-1438G/A with anorexia nervosa and psychopathological traits in the Chinese Han population: a preliminary study.</article-title>
<source/><italic>Asia Pac. Psychiatry</italic>
<volume>9</volume>. <pub-id pub-id-type="doi">10.1111/appy.12284</pub-id>
<pub-id pub-id-type="pmid">28639321</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katila</surname><given-names>H.</given-names></name><name><surname>Appelberg</surname><given-names>B.</given-names></name><name><surname>Hurme</surname><given-names>M.</given-names></name><name><surname>Rimon</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>12</volume>
<fpage>29</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/0920-9964(94)90081-7</pub-id>
<pub-id pub-id-type="pmid">8018583</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuki</surname><given-names>H.</given-names></name><name><surname>Nakai</surname><given-names>S.</given-names></name><name><surname>Hirai</surname><given-names>Y.</given-names></name><name><surname>Akaji</surname><given-names>K.</given-names></name><name><surname>Kiso</surname><given-names>Y.</given-names></name><name><surname>Satoh</surname><given-names>M.</given-names></name></person-group> (<year>1990</year>). <article-title>Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>181</volume>
<fpage>323</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(90)90099-R</pub-id>
<pub-id pub-id-type="pmid">2166677</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>A.</given-names></name><name><surname>Vereker</surname><given-names>E.</given-names></name><name><surname>Nolan</surname><given-names>Y.</given-names></name><name><surname>Brady</surname><given-names>M.</given-names></name><name><surname>Barry</surname><given-names>C.</given-names></name><name><surname>Loscher</surname><given-names>C. E.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>278</volume>
<fpage>19453</fpage>–<lpage>19462</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M301938200</pub-id>
<pub-id pub-id-type="pmid">12609991</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerrigan</surname><given-names>T. L.</given-names></name><name><surname>Randall</surname><given-names>A. D.</given-names></name></person-group> (<year>2013</year>). <article-title>A new player in the “synaptopathy” of Alzheimer’s disease - arc/arg 3.1.</article-title>
<source/><italic>Front. Neurol.</italic>
<volume>4</volume>:<issue>9</issue>
<pub-id pub-id-type="doi">10.3389/fneur.2013.00009</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. G.</given-names></name><name><surname>Kishikawa</surname><given-names>S.</given-names></name><name><surname>Higgins</surname><given-names>A. W.</given-names></name><name><surname>Seong</surname><given-names>I. S.</given-names></name><name><surname>Donovan</surname><given-names>D. J.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>Disruption of neurexin 1 associated with autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>82</volume>
<fpage>199</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.011</pub-id>
<pub-id pub-id-type="pmid">18179900</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi</surname><given-names>T.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Kitajima</surname><given-names>T.</given-names></name><name><surname>Yamanouchi</surname><given-names>Y.</given-names></name><name><surname>Kinoshita</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>No association of complexin1 and complexin2 genes with schizophrenia in a Japanese population.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>82</volume>
<fpage>185</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2005.12.842</pub-id>
<pub-id pub-id-type="pmid">16442780</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krakowiak</surname><given-names>P.</given-names></name><name><surname>Goines</surname><given-names>P. E.</given-names></name><name><surname>Tancredi</surname><given-names>D. J.</given-names></name><name><surname>Ashwood</surname><given-names>P.</given-names></name><name><surname>Hansen</surname><given-names>R. L.</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neonatal cytokine profiles associated with autism spectrum disorder.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>81</volume>
<fpage>442</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.007</pub-id>
<pub-id pub-id-type="pmid">26392128</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristiansen</surname><given-names>L. V.</given-names></name><name><surname>Beneyto</surname><given-names>M.</given-names></name><name><surname>Haroutunian</surname><given-names>V.</given-names></name><name><surname>Meador-Woodruff</surname><given-names>J. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>11</volume>
<fpage>737</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001844</pub-id>
<pub-id pub-id-type="pmid">16702973</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuemmerle-Deschner</surname><given-names>J. B.</given-names></name><name><surname>Ramos</surname><given-names>E.</given-names></name><name><surname>Blank</surname><given-names>N.</given-names></name><name><surname>Roesler</surname><given-names>J.</given-names></name><name><surname>Felix</surname><given-names>S. D.</given-names></name><name><surname>Jung</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Canakinumab (ACZ885 a fully human IgG1 anti-IL-1beta mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).</article-title>
<source/><italic>Arthritis Res. Ther.</italic>
<volume>13</volume>:<issue>R34</issue>. <pub-id pub-id-type="doi">10.1186/ar3266</pub-id>
<pub-id pub-id-type="pmid">21356079</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushima</surname><given-names>Y.</given-names></name><name><surname>Hama</surname><given-names>T.</given-names></name><name><surname>Hatanaka</surname><given-names>H.</given-names></name></person-group> (<year>1992</year>). <article-title>Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>13</volume>
<fpage>267</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1016/0168-0102(92)90039-F</pub-id>
<pub-id pub-id-type="pmid">1321390</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kustanovich</surname><given-names>V.</given-names></name><name><surname>Merriman</surname><given-names>B.</given-names></name><name><surname>Mcgough</surname><given-names>J.</given-names></name><name><surname>Mccracken</surname><given-names>J. T.</given-names></name><name><surname>Smalley</surname><given-names>S. L.</given-names></name><name><surname>Nelson</surname><given-names>S. F.</given-names></name></person-group> (<year>2003</year>). <article-title>Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>8</volume>
<fpage>309</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001247</pub-id>
<pub-id pub-id-type="pmid">12660803</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson-Yuen</surname><given-names>A.</given-names></name><name><surname>Saldivar</surname><given-names>J. S.</given-names></name><name><surname>Sommer</surname><given-names>S.</given-names></name><name><surname>Picker</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Familial deletion within NLGN4 associated with autism and Tourette syndrome.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>16</volume>
<fpage>614</fpage>–<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5202006</pub-id>
<pub-id pub-id-type="pmid">18231125</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemonnier</surname><given-names>E.</given-names></name><name><surname>Degrez</surname><given-names>C.</given-names></name><name><surname>Phelep</surname><given-names>M.</given-names></name><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Josse</surname><given-names>F.</given-names></name><name><surname>Grandgeorge</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>A randomised controlled trial of bumetanide in the treatment of autism in children.</article-title>
<source/><italic>Transl. Psychiatry</italic>
<volume>2</volume>:<issue>e202</issue>. <pub-id pub-id-type="doi">10.1038/tp.2012.124</pub-id>
<pub-id pub-id-type="pmid">23233021</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepeta</surname><given-names>K.</given-names></name><name><surname>Lourenco</surname><given-names>M. V.</given-names></name><name><surname>Schweitzer</surname><given-names>B. C.</given-names></name><name><surname>Martino Adami</surname><given-names>P. V.</given-names></name><name><surname>Banerjee</surname><given-names>P.</given-names></name><name><surname>Catuara-Solarz</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>138</volume>
<fpage>785</fpage>–<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13713</pub-id>
<pub-id pub-id-type="pmid">27333343</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Barger</surname><given-names>S. W.</given-names></name><name><surname>Griffin</surname><given-names>W. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>1605</fpage>–<lpage>1611</lpage>. <pub-id pub-id-type="pmid">12629164</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C. C.</given-names></name><name><surname>Edelson</surname><given-names>B. T.</given-names></name></person-group> (<year>2017</year>). <article-title>New insights into the role of IL-1beta in experimental autoimmune encephalomyelitis and multiple sclerosis.</article-title>
<source/><italic>J. Immunol.</italic>
<volume>198</volume>
<fpage>4553</fpage>–<lpage>4560</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1700263</pub-id>
<pub-id pub-id-type="pmid">28583987</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipina</surname><given-names>T. V.</given-names></name><name><surname>Zai</surname><given-names>C.</given-names></name><name><surname>Hlousek</surname><given-names>D.</given-names></name><name><surname>Roder</surname><given-names>J. C.</given-names></name><name><surname>Wong</surname><given-names>A. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>7654</fpage>–<lpage>7666</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0091-13.2013</pub-id>
<pub-id pub-id-type="pmid">23637159</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname><given-names>L. M.</given-names></name><name><surname>Baker</surname><given-names>S. A.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>MECP2 disorders: from the clinic to mice and back.</article-title>
<source/><italic>J. Clin. Invest.</italic>
<volume>125</volume>
<fpage>2914</fpage>–<lpage>2923</lpage>. <pub-id pub-id-type="doi">10.1172/JCI78167</pub-id>
<pub-id pub-id-type="pmid">26237041</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longhena</surname><given-names>F.</given-names></name><name><surname>Faustini</surname><given-names>G.</given-names></name><name><surname>Missale</surname><given-names>C.</given-names></name><name><surname>Pizzi</surname><given-names>M.</given-names></name><name><surname>Spano</surname><given-names>P.</given-names></name><name><surname>Bellucci</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>The contribution of alpha-synuclein spreading to Parkinson’s disease synaptopathy.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2017</volume>:<issue>5012129</issue>. <pub-id pub-id-type="doi">10.1155/2017/5012129</pub-id>
<pub-id pub-id-type="pmid">28133550</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandolesi</surname><given-names>G.</given-names></name><name><surname>De Vito</surname><given-names>F.</given-names></name><name><surname>Musella</surname><given-names>A.</given-names></name><name><surname>Gentile</surname><given-names>A.</given-names></name><name><surname>Bullitta</surname><given-names>S.</given-names></name><name><surname>Fresegna</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>miR-142-3p is a key regulator of IL-1beta-dependent synaptopathy in neuroinflammation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>546</fpage>–<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0851-16.2016</pub-id>
<pub-id pub-id-type="pmid">28100738</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandolesi</surname><given-names>G.</given-names></name><name><surname>Musella</surname><given-names>A.</given-names></name><name><surname>Gentile</surname><given-names>A.</given-names></name><name><surname>Grasselli</surname><given-names>G.</given-names></name><name><surname>Haji</surname><given-names>N.</given-names></name><name><surname>Sepman</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Interleukin-1beta alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>33</volume>
<fpage>12105</fpage>–<lpage>12121</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5369-12.2013</pub-id>
<pub-id pub-id-type="pmid">23864696</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maroso</surname><given-names>M.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Aronica</surname><given-names>E.</given-names></name><name><surname>Iyer</surname><given-names>A. M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.</article-title>
<source/><italic>Nat. Med.</italic>
<volume>16</volume>
<fpage>413</fpage>–<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2127</pub-id>
<pub-id pub-id-type="pmid">20348922</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maroso</surname><given-names>M.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Bianchi</surname><given-names>M. E.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Interleukin-1 type 1 receptor/toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1.</article-title>
<source/><italic>J. Intern. Med.</italic>
<volume>270</volume>
<fpage>319</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2796.2011.02431.x</pub-id>
<pub-id pub-id-type="pmid">21793950</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millan</surname><given-names>M. J.</given-names></name></person-group> (<year>2013</year>). <article-title>An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>68</volume>
<fpage>2</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.11.015</pub-id>
<pub-id pub-id-type="pmid">23246909</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Shin</surname><given-names>A. H.</given-names></name><name><surname>Thayer</surname><given-names>S. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms.</article-title>
<source/><italic>J. Neuroimmune Pharmacol.</italic>
<volume>7</volume>
<fpage>571</fpage>–<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1007/s11481-012-9342-7</pub-id>
<pub-id pub-id-type="pmid">22311599</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missault</surname><given-names>S.</given-names></name><name><surname>Van Den Eynde</surname><given-names>K.</given-names></name><name><surname>Vanden Berghe</surname><given-names>W.</given-names></name><name><surname>Fransen</surname><given-names>E.</given-names></name><name><surname>Weeren</surname><given-names>A.</given-names></name><name><surname>Timmermans</surname><given-names>J. P.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>42</volume>
<fpage>138</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2014.06.013</pub-id>
<pub-id pub-id-type="pmid">24973728</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montani</surname><given-names>C.</given-names></name><name><surname>Ramos-Brossier</surname><given-names>M.</given-names></name><name><surname>Ponzoni</surname><given-names>L.</given-names></name><name><surname>Gritti</surname><given-names>L.</given-names></name><name><surname>Cwetsch</surname><given-names>A. W.</given-names></name><name><surname>Braida</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>The X-linked intellectual disability protein IL1RAPL1 regulates dendrite complexity.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>6606</fpage>–<lpage>6627</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3775-16.2017</pub-id>
<pub-id pub-id-type="pmid">28576939</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraes</surname><given-names>C. A.</given-names></name><name><surname>Santos</surname><given-names>G.</given-names></name><name><surname>De Sampaio e Spohr</surname><given-names>T. C.</given-names></name><name><surname>D’avila</surname><given-names>J. C.</given-names></name><name><surname>Lima</surname><given-names>F. R.</given-names></name><name><surname>Benjamim</surname><given-names>C. F.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Activated microglia-induced deficits in excitatory synapses through IL-1β: implications for cognitive impairment in sepsis.</article-title>
<source/><italic>Mol. Neurobiol.</italic>
<volume>52</volume>
<fpage>653</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8868-5</pub-id>
<pub-id pub-id-type="pmid">25257696</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>C. A.</given-names></name><name><surname>Lynch</surname><given-names>M. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>273</volume>
<fpage>12161</fpage>–<lpage>12168</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.20.12161</pub-id>
<pub-id pub-id-type="pmid">9575163</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>K. N.</given-names></name><name><surname>Parry-Jones</surname><given-names>A. R.</given-names></name><name><surname>Allan</surname><given-names>S. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Interleukin-1 and acute brain injury.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>18</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00018</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najjar</surname><given-names>S.</given-names></name><name><surname>Pearlman</surname><given-names>D. M.</given-names></name><name><surname>Alper</surname><given-names>K.</given-names></name><name><surname>Najjar</surname><given-names>A.</given-names></name><name><surname>Devinsky</surname><given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>Neuroinflammation and psychiatric illness.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>10</volume>:<issue>43</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-10-43</pub-id>
<pub-id pub-id-type="pmid">23547920</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>M.</given-names></name><name><surname>Niidome</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Akaike</surname><given-names>A.</given-names></name><name><surname>Kihara</surname><given-names>T.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>25</volume>
<fpage>649</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05309.x</pub-id>
<pub-id pub-id-type="pmid">17328769</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh-Nishi</surname><given-names>A.</given-names></name><name><surname>Obayashi</surname><given-names>S.</given-names></name><name><surname>Sugihara</surname><given-names>I.</given-names></name><name><surname>Minamimoto</surname><given-names>T.</given-names></name><name><surname>Suhara</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1363</volume>
<fpage>170</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.09.054</pub-id>
<pub-id pub-id-type="pmid">20863817</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oitzl</surname><given-names>M. S.</given-names></name><name><surname>Van Oers</surname><given-names>H.</given-names></name><name><surname>Schobitz</surname><given-names>B.</given-names></name><name><surname>De Kloet</surname><given-names>E. R.</given-names></name></person-group> (<year>1993</year>). <article-title>Interleukin-1 beta, but not interleukin-6 impairs spatial navigation learning.</article-title>
<source/><italic>Brain Res.</italic>
<volume>613</volume>
<fpage>160</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(93)90468-3</pub-id><pub-id pub-id-type="pmid">8348300</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Keeffe</surname><given-names>G. W.</given-names></name></person-group> (<year>2017</year>). <article-title>A new role for placental IL-6 signalling in determining neurodevelopmental outcome.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>62</volume>
<fpage>9</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2017.02.011</pub-id>
<pub-id pub-id-type="pmid">28216086</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldmeadow</surname><given-names>C.</given-names></name><name><surname>Mossman</surname><given-names>D.</given-names></name><name><surname>Evans</surname><given-names>T. J.</given-names></name><name><surname>Holliday</surname><given-names>E. G.</given-names></name><name><surname>Tooney</surname><given-names>P. A.</given-names></name><name><surname>Cairns</surname><given-names>M. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci.</article-title>
<source/><italic>J. Psychiatr. Res.</italic>
<volume>52</volume>
<fpage>44</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2014.01.011</pub-id>
<pub-id pub-id-type="pmid">24507884</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parish</surname><given-names>C. L.</given-names></name><name><surname>Finkelstein</surname><given-names>D. I.</given-names></name><name><surname>Tripanichkul</surname><given-names>W.</given-names></name><name><surname>Satoskar</surname><given-names>A. R.</given-names></name><name><surname>Drago</surname><given-names>J.</given-names></name><name><surname>Horne</surname><given-names>M. K.</given-names></name></person-group> (<year>2002</year>). <article-title>The role of interleukin-1 interleukin-6 and glia in inducing growth of neuronal terminal arbors in mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>22</volume>
<fpage>8034</fpage>–<lpage>8041</lpage>. <pub-id pub-id-type="pmid">12223557</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>S. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Immune dysregulation and cognitive vulnerability in the aging brain: interactions of microglia, IL-1β, BDNF and synaptic plasticity.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>96</volume>
<fpage>11</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.12.020</pub-id>
<pub-id pub-id-type="pmid">25549562</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlowsky</surname><given-names>A.</given-names></name><name><surname>Gianfelice</surname><given-names>A.</given-names></name><name><surname>Pallotto</surname><given-names>M.</given-names></name><name><surname>Zanchi</surname><given-names>A.</given-names></name><name><surname>Vara</surname><given-names>H.</given-names></name><name><surname>Khelfaoui</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation.</article-title>
<source/><italic>Curr. Biol.</italic>
<volume>20</volume>
<fpage>103</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2009.12.030</pub-id>
<pub-id pub-id-type="pmid">20096586</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prieto</surname><given-names>G. A.</given-names></name><name><surname>Snigdha</surname><given-names>S.</given-names></name><name><surname>Baglietto-Vargas</surname><given-names>D.</given-names></name><name><surname>Smith</surname><given-names>E. D.</given-names></name><name><surname>Berchtold</surname><given-names>N. C.</given-names></name><name><surname>Tong</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>112</volume>
<fpage>E5078</fpage>–<lpage>E5087</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1514486112</pub-id>
<pub-id pub-id-type="pmid">26305968</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rachal Pugh</surname><given-names>C.</given-names></name><name><surname>Fleshner</surname><given-names>M.</given-names></name><name><surname>Watkins</surname><given-names>L. R.</given-names></name><name><surname>Maier</surname><given-names>S. F.</given-names></name><name><surname>Rudy</surname><given-names>J. W.</given-names></name></person-group> (<year>2001</year>). <article-title>The immune system and memory consolidation: a role for the cytokine IL-1beta.</article-title>
<source/><italic>Neurosci. Biobehav. Rev.</italic>
<volume>25</volume>
<fpage>29</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0149-7634(00)00048-8</pub-id><pub-id pub-id-type="pmid">11166076</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimondo</surname><given-names>J. V.</given-names></name><name><surname>Richards</surname><given-names>B. A.</given-names></name><name><surname>Woodin</surname><given-names>M. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuronal chloride and excitability - the big impact of small changes.</article-title>
<source/><italic>Curr. Opin. Neurobiol.</italic>
<volume>43</volume>
<fpage>35</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2016.11.012</pub-id>
<pub-id pub-id-type="pmid">27992777</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Brossier</surname><given-names>M.</given-names></name><name><surname>Montani</surname><given-names>C.</given-names></name><name><surname>Lebrun</surname><given-names>N.</given-names></name><name><surname>Gritti</surname><given-names>L.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><name><surname>Seminatore-Nole</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Novel IL1RAPL1 mutations associated with intellectual disability impair synaptogenesis.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>24</volume>
<fpage>1106</fpage>–<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu523</pub-id>
<pub-id pub-id-type="pmid">25305082</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>F. M.</given-names></name><name><surname>Allan</surname><given-names>S. M.</given-names></name><name><surname>Rothwell</surname><given-names>N. J.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>A dual role for interleukin-1 in LTP in mouse hippocampal slices.</article-title>
<source/><italic>J. Neuroimmunol.</italic>
<volume>144</volume>
<fpage>61</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2003.08.030</pub-id>
<pub-id pub-id-type="pmid">14597099</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Furlan</surname><given-names>R.</given-names></name><name><surname>De Chiara</surname><given-names>V.</given-names></name><name><surname>Motta</surname><given-names>C.</given-names></name><name><surname>Studer</surname><given-names>V.</given-names></name><name><surname>Mori</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Interleukin-1beta causes synaptic hyperexcitability in multiple sclerosis.</article-title>
<source/><italic>Ann. Neurol.</italic>
<volume>71</volume>
<fpage>76</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1002/ana.22512</pub-id>
<pub-id pub-id-type="pmid">22275254</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Motta</surname><given-names>C.</given-names></name><name><surname>Studer</surname><given-names>V.</given-names></name><name><surname>Macchiarulo</surname><given-names>G.</given-names></name><name><surname>Volpe</surname><given-names>E.</given-names></name><name><surname>Barbieri</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.</article-title>
<source/><italic>Mol. Neurodegener.</italic>
<volume>9</volume>:<issue>56</issue>. <pub-id pub-id-type="doi">10.1186/1750-1326-9-56</pub-id>
<pub-id pub-id-type="pmid">25495224</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitsu</surname><given-names>H.</given-names></name><name><surname>Kato</surname><given-names>M.</given-names></name><name><surname>Mizuguchi</surname><given-names>T.</given-names></name><name><surname>Hamada</surname><given-names>K.</given-names></name><name><surname>Osaka</surname><given-names>H.</given-names></name><name><surname>Tohyama</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy.</article-title>
<source/><italic>Nat. Genet.</italic>
<volume>40</volume>
<fpage>782</fpage>–<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1038/ng.150</pub-id>
<pub-id pub-id-type="pmid">18469812</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuelsson</surname><given-names>A. M.</given-names></name><name><surname>Jennische</surname><given-names>E.</given-names></name><name><surname>Hansson</surname><given-names>H. A.</given-names></name><name><surname>Holmang</surname><given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning.</article-title>
<source/><italic>Am. J. Physiol. Regul. Integr. Comp. Physiol.</italic>
<volume>290</volume>
<fpage>R1345</fpage>–<lpage>R1356</lpage>. <pub-id pub-id-type="pmid">16357100</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafers</surname><given-names>M.</given-names></name><name><surname>Sorkin</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Effect of cytokines on neuronal excitability.</article-title>
<source/><italic>Neurosci. Lett.</italic>
<volume>437</volume>
<fpage>188</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2008.03.052</pub-id>
<pub-id pub-id-type="pmid">18420346</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiavone</surname><given-names>S.</given-names></name><name><surname>Trabace</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Inflammation, stress response, and redox dysregulation biomarkers: clinical outcomes and pharmacological implications for psychosis.</article-title>
<source/><italic>Front. Psychiatry</italic>
<volume>8</volume>:<issue>203</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2017.00203</pub-id>
<pub-id pub-id-type="pmid">29118723</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A.</given-names></name><name><surname>Bialas</surname><given-names>A. R.</given-names></name><name><surname>De Rivera</surname><given-names>H.</given-names></name><name><surname>Davis</surname><given-names>A.</given-names></name><name><surname>Hammond</surname><given-names>T. R.</given-names></name><name><surname>Kamitaki</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Schizophrenia risk from complex variation of complement component 4.</article-title>
<source/><italic>Nature</italic>
<volume>530</volume>
<fpage>177</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1038/nature16549</pub-id>
<pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soderlund</surname><given-names>J.</given-names></name><name><surname>Schroder</surname><given-names>J.</given-names></name><name><surname>Nordin</surname><given-names>C.</given-names></name><name><surname>Samuelsson</surname><given-names>M.</given-names></name><name><surname>Walther-Jallow</surname><given-names>L.</given-names></name><name><surname>Karlsson</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Activation of brain interleukin-1beta in schizophrenia.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>14</volume>
<fpage>1069</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.52</pub-id>
<pub-id pub-id-type="pmid">19920835</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuroligins and neurexins link synaptic function to cognitive disease.</article-title>
<source/><italic>Nature</italic>
<volume>455</volume>
<fpage>903</fpage>–<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1038/nature07456</pub-id>
<pub-id pub-id-type="pmid">18923512</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Matsuzaki</surname><given-names>H.</given-names></name><name><surname>Iwata</surname><given-names>K.</given-names></name><name><surname>Kameno</surname><given-names>Y.</given-names></name><name><surname>Shimmura</surname><given-names>C.</given-names></name><name><surname>Kawai</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.</article-title>
<source/><italic>PLoS One</italic>
<volume>6</volume>:<issue>e20470</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0020470</pub-id>
<pub-id pub-id-type="pmid">21647375</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Wengert</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>113</volume>
<fpage>751</fpage>–<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1524013113</pub-id>
<pub-id pub-id-type="pmid">26733678</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarnow-Mordi</surname><given-names>W.</given-names></name><name><surname>Isaacs</surname><given-names>D.</given-names></name><name><surname>Smart</surname><given-names>D. H.</given-names></name><name><surname>Stenson</surname><given-names>B.</given-names></name><name><surname>Haque</surname><given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurodevelopmental impairment and neonatal infections.</article-title>
<source/><italic>JAMA</italic>
<volume>293</volume>
<issue>932</issue>; <comment>author reply 932</comment>.</mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thapar</surname><given-names>A.</given-names></name><name><surname>Langley</surname><given-names>K.</given-names></name><name><surname>Owen</surname><given-names>M. J.</given-names></name><name><surname>O’donovan</surname><given-names>M. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Advances in genetic findings on attention deficit hyperactivity disorder.</article-title>
<source/><italic>Psychol. Med.</italic>
<volume>37</volume>
<fpage>1681</fpage>–<lpage>1692</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291707000773</pub-id>
<pub-id pub-id-type="pmid">17506925</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>P. M.</given-names></name><name><surname>Sower</surname><given-names>A. C.</given-names></name><name><surname>Perrone-Bizzozero</surname><given-names>N. I.</given-names></name></person-group> (<year>1998</year>). <article-title>Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>43</volume>
<fpage>239</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(97)00204-7</pub-id><pub-id pub-id-type="pmid">9513732</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasoni</surname><given-names>R.</given-names></name><name><surname>Morini</surname><given-names>R.</given-names></name><name><surname>Lopez-Atalaya</surname><given-names>J. P.</given-names></name><name><surname>Corradini</surname><given-names>I.</given-names></name><name><surname>Canzi</surname><given-names>A.</given-names></name><name><surname>Rasile</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Lack of IL-1R8 in neurons causes hyperactivation of IL-1 receptor pathway and induces MECP2-dependent synaptic defects.</article-title>
<source/><italic>Elife</italic>
<volume>6</volume>:<issue>e21735</issue>. <pub-id pub-id-type="doi">10.7554/eLife.21735</pub-id>
<pub-id pub-id-type="pmid">28347403</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toro</surname><given-names>C.</given-names></name><name><surname>Deakin</surname><given-names>J. F.</given-names></name></person-group> (<year>2005</year>). <article-title>NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.</article-title>
<source/><italic>Schizophr. Res.</italic>
<volume>80</volume>
<fpage>323</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2005.07.003</pub-id>
<pub-id pub-id-type="pmid">16140506</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Holmes</surname><given-names>G. L.</given-names></name><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name><name><surname>Khazipov</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Timing of the developmental switch in GABA(A) mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramicidin perforated patch and extracellular recordings.</article-title>
<source/><italic>Epilepsia</italic>
<volume>48(Suppl. 5)</volume>, <fpage>96</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01295.x</pub-id>
<pub-id pub-id-type="pmid">17910587</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyzio</surname><given-names>R.</given-names></name><name><surname>Nardou</surname><given-names>R.</given-names></name><name><surname>Ferrari</surname><given-names>D. C.</given-names></name><name><surname>Tsintsadze</surname><given-names>T.</given-names></name><name><surname>Shahrokhi</surname><given-names>A.</given-names></name><name><surname>Eftekhari</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring.</article-title>
<source/><italic>Science</italic>
<volume>343</volume>
<fpage>675</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1126/science.1247190</pub-id>
<pub-id pub-id-type="pmid">24503856</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschach</surname><given-names>A.</given-names></name><name><surname>Grasshoff</surname><given-names>U.</given-names></name><name><surname>Beck-Woedl</surname><given-names>S.</given-names></name><name><surname>Dufke</surname><given-names>C.</given-names></name><name><surname>Bauer</surname><given-names>C.</given-names></name><name><surname>Kehrer</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Next-generation sequencing in X-linked intellectual disability.</article-title>
<source/><italic>Eur. J. Hum. Genet.</italic>
<volume>23</volume>
<fpage>1513</fpage>–<lpage>1518</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2015.5</pub-id>
<pub-id pub-id-type="pmid">25649377</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaags</surname><given-names>A. K.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><name><surname>Sato</surname><given-names>D.</given-names></name><name><surname>Goodenberger</surname><given-names>M.</given-names></name><name><surname>Stein</surname><given-names>Q. P.</given-names></name><name><surname>Curran</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Rare deletions at the neurexin 3 locus in autism spectrum disorder.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>90</volume>
<fpage>133</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.025</pub-id>
<pub-id pub-id-type="pmid">22209245</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valnegri</surname><given-names>P.</given-names></name><name><surname>Montrasio</surname><given-names>C.</given-names></name><name><surname>Brambilla</surname><given-names>D.</given-names></name><name><surname>Ko</surname><given-names>J.</given-names></name><name><surname>Passafaro</surname><given-names>M.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPdelta and RhoGAP2.</article-title>
<source/><italic>Hum. Mol. Genet.</italic>
<volume>20</volume>
<fpage>4797</fpage>–<lpage>4809</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr418</pub-id>
<pub-id pub-id-type="pmid">21926414</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Esch</surname><given-names>H.</given-names></name><name><surname>Bauters</surname><given-names>M.</given-names></name><name><surname>Ignatius</surname><given-names>J.</given-names></name><name><surname>Jansen</surname><given-names>M.</given-names></name><name><surname>Raynaud</surname><given-names>M.</given-names></name><name><surname>Hollanders</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Duplication of the <italic>MECP2</italic> region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.</article-title>
<source/><italic>Am. J. Hum. Genet.</italic>
<volume>77</volume>
<fpage>442</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1086/444549</pub-id>
<pub-id pub-id-type="pmid">16080119</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Balosso</surname><given-names>S.</given-names></name><name><surname>Ravizza</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>The role of cytokines in the pathophysiology of epilepsy.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>22</volume>
<fpage>797</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2008.03.009</pub-id>
<pub-id pub-id-type="pmid">18495419</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viviani</surname><given-names>B.</given-names></name><name><surname>Bartesaghi</surname><given-names>S.</given-names></name><name><surname>Gardoni</surname><given-names>F.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name><name><surname>Behrens</surname><given-names>M. M.</given-names></name><name><surname>Bartfai</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>23</volume>
<fpage>8692</fpage>–<lpage>8700</lpage>. <pub-id pub-id-type="pmid">14507968</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viviani</surname><given-names>B.</given-names></name><name><surname>Gardoni</surname><given-names>F.</given-names></name><name><surname>Marinovich</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Cytokines and neuronal ion channels in health and disease.</article-title>
<source/><italic>Int. Rev. Neurobiol.</italic>
<volume>82</volume>
<fpage>247</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/S0074-7742(07)82013-7</pub-id><pub-id pub-id-type="pmid">17678965</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>J. A.</given-names></name></person-group> (<year>1996</year>). <article-title>Is IL-6 both a cytokine and a neurotrophic factor?</article-title>
<source/><italic>J. Exp. Med.</italic>
<volume>183</volume>
<fpage>2417</fpage>–<lpage>2419</lpage>. <pub-id pub-id-type="doi">10.1084/jem.183.6.2417</pub-id><pub-id pub-id-type="pmid">8676061</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Fukuda</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Development and regulation of chloride homeostasis in the central nervous system.</article-title>
<source/><italic>Front. Cell. Neurosci.</italic>
<volume>9</volume>:<issue>371</issue>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00371</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>H.</given-names></name><name><surname>Zou</surname><given-names>H.</given-names></name><name><surname>Sheikh</surname><given-names>A. M.</given-names></name><name><surname>Malik</surname><given-names>M.</given-names></name><name><surname>Dobkin</surname><given-names>C.</given-names></name><name><surname>Brown</surname><given-names>W. T.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>8</volume>:<issue>52</issue>. <pub-id pub-id-type="doi">10.1186/1742-2094-8-52</pub-id>
<pub-id pub-id-type="pmid">21595886</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wischhof</surname><given-names>L.</given-names></name><name><surname>Irrsack</surname><given-names>E.</given-names></name><name><surname>Osorio</surname><given-names>C.</given-names></name><name><surname>Koch</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Prenatal LPS-exposure–a neurodevelopmental rat model of schizophrenia–differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>57</volume>
<fpage>17</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2014.10.004</pub-id>
<pub-id pub-id-type="pmid">25455585</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>J.</given-names></name><name><surname>Kimura</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Ishizuka</surname><given-names>K.</given-names></name><name><surname>Kushima</surname><given-names>I.</given-names></name><name><surname>Arioka</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Resequencing and association analysis of six PSD-95-related genes as possible susceptibility genes for schizophrenia and autism spectrum disorders.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>6</volume>:<issue>27491</issue>. <pub-id pub-id-type="doi">10.1038/srep27491</pub-id>
<pub-id pub-id-type="pmid">27271353</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Hatanaka</surname><given-names>H.</given-names></name></person-group> (<year>1994</year>). <article-title>Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death.</article-title>
<source/><italic>Brain Res.</italic>
<volume>643</volume>
<fpage>173</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(94)90023-X</pub-id>
<pub-id pub-id-type="pmid">7913397</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>H. Q.</given-names></name><name><surname>Banos</surname><given-names>M. A.</given-names></name><name><surname>Herregodts</surname><given-names>P.</given-names></name><name><surname>Hooghe</surname><given-names>R.</given-names></name><name><surname>Hooghe-Peters</surname><given-names>E. L.</given-names></name></person-group> (<year>1992</year>). <article-title>Expression of interleukin (IL)-1 beta, IL-6 and their respective receptors in the normal rat brain and after injury.</article-title>
<source/><italic>Eur. J. Immunol.</italic>
<volume>22</volume>
<fpage>2963</fpage>–<lpage>2971</lpage>. <pub-id pub-id-type="doi">10.1002/eji.1830221131</pub-id>
<pub-id pub-id-type="pmid">1425920</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasumura</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Yamazaki</surname><given-names>M.</given-names></name><name><surname>Abe</surname><given-names>M.</given-names></name><name><surname>Natsume</surname><given-names>R.</given-names></name><name><surname>Kanno</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours.</article-title>
<source/><italic>Sci. Rep.</italic>
<volume>4</volume>:<issue>6613</issue>. <pub-id pub-id-type="doi">10.1038/srep06613</pub-id>
<pub-id pub-id-type="pmid">25312502</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>M.</given-names></name><name><surname>Berglund</surname><given-names>K.</given-names></name><name><surname>Augustine</surname><given-names>G.</given-names></name><name><surname>Liedtke</surname><given-names>W.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel repression of Kcc2 transcription by REST-RE-1 controls developmental switch in neuronal chloride.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>14652</fpage>–<lpage>14662</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2934-09.2009</pub-id>
<pub-id pub-id-type="pmid">19923298</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yirmiya</surname><given-names>R.</given-names></name><name><surname>Goshen</surname><given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Immune modulation of learning, memory, neural plasticity and neurogenesis.</article-title>
<source/><italic>Brain Behav. Immun.</italic>
<volume>25</volume>
<fpage>181</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2010.10.015</pub-id>
<pub-id pub-id-type="pmid">20970492</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Yasumura</surname><given-names>M.</given-names></name><name><surname>Uemura</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>S. J.</given-names></name><name><surname>Ra</surname><given-names>M.</given-names></name><name><surname>Taguchi</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase delta.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>13485</fpage>–<lpage>13499</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2136-11.2011</pub-id>
<pub-id pub-id-type="pmid">21940441</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.</article-title>
<source/><italic>Psychopharmacology</italic>
<volume>231</volume>
<fpage>685</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-013-3297-0</pub-id>
<pub-id pub-id-type="pmid">24114429</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>